- 2025.12.01
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated phenytoin sodium Injection, solution 250 mg Current Unavailable Manufacturing 28/11/2025 phenytoin sodium Injection, solution 100 mg Current Unavailable Manufacturing 28/11/2025 codeine phosphate hemihydrate Oral Liquid, solution 5 mg/mL Current Unavailable Manufacturing 28/11/2025 topiramate Tablet, film coated 25 mg Current Unavailable Manufacturing 28/11/2025 midazolam Injection, solution 5 mg/mL Current Limited Availability Manufacturing 28/11/2025 metformin hydrochloride Tablet, film coated 500 mg Resolved Available Manufacturing 28/11/2025 olanzapine Tablet, film coated 5 mg Current Unavailable Manufacturing 28/11/2025 olanzapine Tablet, film coated 7.5 mg Current Unavailable Manufacturing 28/11/2025 donepezil hydrochloride Tablet, film coated 5 mg Anticipated Available Manufacturing 28/11/2025 lamivudine Tablet, film coated 300 mg Anticipated Available Manufacturing 28/11/2025 levetiracetam Tablet, film coated 1000 mg Resolved Available Manufacturing 28/11/2025 sildenafil citrate Tablet, film coated 140.45 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 28/11/2025 ondansetron hydrochloride dihydrate Tablet, film coated 9.972 mg Current Limited Availability Manufacturing 28/11/2025 atorvastatin calcium trihydrate Tablet, film coated 21.69 mg Resolved Available Manufacturing 28/11/2025 indapamide hemihydrate Tablet, sugar coated 2.5 mg Current Unavailable Manufacturing 28/11/2025 montelukast sodium Tablet, chewable 4.16 mg Current Unavailable Manufacturing 28/11/2025 montelukast sodium Tablet, film coated 10.4 mg Anticipated Available Manufacturing 28/11/2025 montelukast sodium Tablet, chewable 4.16 mg Current Unavailable Manufacturing 28/11/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 28/11/2025 finasteride Tablet, film coated 1 mg Resolved Available Manufacturing 28/11/2025 nystatin Oral Liquid, suspension 100000 IU/mL Resolved Available Unexpected increase in consumer demand 28/11/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Anticipated Available Manufacturing 28/11/2025 ezetimibe Tablet, uncoated 10 mg Resolved Available Unexpected increase in consumer demand 28/11/2025 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 28/11/2025 lamotrigine Tablet, uncoated 25 mg Current Limited Availability Commercial Changes / Commercial viability 28/11/2025 cyproterone acetate Tablet, uncoated 100 mg Anticipated Available Manufacturing 28/11/2025 tobramycin Inhalation, conventional 60 mg/mL Anticipated Available Manufacturing 28/11/2025 nizatidine Capsule, hard 150 mg Resolved Available Manufacturing 28/11/2025 Semaglutide Injection, solution 1.34 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 28/11/2025 prasugrel Tablet, film coated 5 mg Current Unavailable Commercial Changes / Commercial viability 28/11/2025 lanreotide acetate Injection, solution 100 mg Anticipated Available Manufacturing 28/11/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 28/11/2025 naltrexone hydrochloride Tablet, film coated 50 mg Anticipated Available Manufacturing 28/11/2025 levothyroxine sodium Tablet 200 microgram Resolved Available Unexpected increase in consumer demand 28/11/2025 atracurium besilate Injection, solution 10 mg/mL Anticipated Available Manufacturing 28/11/2025 mivacurium chloride Injection, solution 2.14 mg/mL Current Unavailable Manufacturing 28/11/2025 framycetin sulfate~gramicidin~dexamethasone Ear Drops 5 mg/mL~.05 mg/mL~.5 mg/mL Anticipated Available Manufacturing 28/11/2025 phenytoin sodium Injection, solution 100 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 28/11/2025 phenytoin sodium Injection, solution 250 mg Current Limited Availability Manufacturing 28/11/2025 cisatracurium besilate Injection, solution 6.7 mg/mL Anticipated Available Manufacturing 28/11/2025 naratriptan hydrochloride Tablet, film coated 2.78 mg Current Limited Availability Manufacturing 28/11/2025 pramipexole dihydrochloride monohydrate Tablet, uncoated 1 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 28/11/2025 valaciclovir hydrochloride Tablet, film coated 1112 mg Resolved Available Manufacturing 28/11/2025 risperidone Injection, modified release 50 mg Resolved Available Manufacturing 28/11/2025 verapamil hydrochloride Tablet, modified release 240 mg Resolved Available Manufacturing 27/11/2025 glimepiride Tablet, uncoated 2 mg Anticipated Available Manufacturing 27/11/2025 acetazolamide sodium Injection, powder for 549.5 mg Current Unavailable Manufacturing 27/11/2025 pentetic acid Injection, powder for 5 mg Current Unavailable Manufacturing 27/11/2025 lamotrigine Tablet, chewable 100 mg Current Limited Availability Manufacturing 27/11/2025 risperidone Tablet, film coated 2 mg Current Limited Availability Manufacturing 27/11/2025 methylphenidate hydrochloride Capsule, modified release 10 mg Resolved Available Manufacturing 27/11/2025 bisoprolol fumarate Tablet 2.5 mg Current Unavailable Manufacturing 27/11/2025 bisoprolol fumarate Tablet 10 mg Current Limited Availability Manufacturing 27/11/2025 levetiracetam Tablet, film coated 500 mg Current Limited Availability Manufacturing 27/11/2025 ropivacaine hydrochloride Injection, solution 2 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 27/11/2025 ropivacaine hydrochloride Injection, solution 7.5 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 27/11/2025 cobicistat~atazanavir Tablet, film coated 150 mg~300 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 27/11/2025 methylphenidate hydrochloride Capsule, modified release 60 mg Current Limited Availability Manufacturing 27/11/2025 risperidone Tablet, film coated 1 mg Anticipated Available Manufacturing 27/11/2025 risperidone Tablet, film coated 2 mg Anticipated Available Manufacturing 27/11/2025 letrozole Tablet, film coated 2.5 mg Resolved Available Manufacturing 27/11/2025 paclitaxel Injection, powder for 100 mg Current Limited Availability Manufacturing 27/11/2025 methylphenidate hydrochloride Capsule, hard 40 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 27/11/2025 methylphenidate hydrochloride Capsule, hard 20 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 27/11/2025 methylphenidate hydrochloride Capsule, hard 30 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 27/11/2025 methylphenidate hydrochloride Capsule, hard 10 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 27/11/2025 methylphenidate hydrochloride Capsule, hard 60 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 27/11/2025 methylphenidate hydrochloride Capsule, modified release 40 mg Current Unavailable Manufacturing 27/11/2025 lamotrigine Tablet, dispersible 100 mg Current Limited Availability Manufacturing 27/11/2025 lamotrigine Tablet, dispersible 200 mg Current Unavailable Manufacturing 27/11/2025 verapamil hydrochloride Tablet, film coated 240 mg Current Limited Availability Manufacturing 26/11/2025 valaciclovir Tablet, film coated 500 mg Current Limited Availability Manufacturing 26/11/2025 sodium pyrophosphate Injection, powder for 30 mg Current Unavailable Manufacturing 26/11/2025 risperidone Tablet 1 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 26/11/2025 losartan potassium Tablet, film coated 50 mg Current Unavailable Manufacturing 26/11/2025 losartan potassium Tablet, film coated 25 mg Current Unavailable Manufacturing 26/11/2025 mycophenolate mofetil Tablet, film coated 500 mg Current Limited Availability Manufacturing 26/11/2025 nystatin Oral Liquid 100000 IU/mL Resolved Available Commercial Changes / Commercial viability 26/11/2025 letrozole Tablet, film coated 2.5 mg Current Unavailable Manufacturing 26/11/2025 atorvastatin calcium trihydrate Tablet, film coated 21.69 mg Current Unavailable Manufacturing 26/11/2025 amlodipine besilate~atorvastatin calcium trihydrate Tablet, film coated 13.88 mg~10.844 mg Resolved Available Manufacturing 26/11/2025 midazolam Injection, solution 50 mg Current Unavailable Manufacturing 26/11/2025 flecainide acetate Tablet, uncoated 50 mg Current Limited Availability Manufacturing 26/11/2025 rosuvastatin calcium Tablet, film coated 20.84 mg Current Unavailable Unexpected increase in consumer demand 26/11/2025 pregabalin Capsule, hard 150 mg Current Limited Availability Unexpected increase in consumer demand 26/11/2025 pregabalin Capsule, hard 25 mg Resolved Available Manufacturing 26/11/2025 levetiracetam Solution 100 mg/mL Current Limited Availability Manufacturing 26/11/2025 atomoxetine hydrochloride Capsule, hard 20.57 mg Current Unavailable Manufacturing 26/11/2025 dabigatran etexilate mesilate Capsule, hard 172.95 mg Current Unavailable Manufacturing 26/11/2025 metaraminol tartrate Injection, solution 19 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 26/11/2025 tamoxifen citrate Tablet 30.34 mg Anticipated Available Manufacturing 26/11/2025 sunitinib Capsule 12.5 mg Anticipated Available Manufacturing 26/11/2025 tofacitinib citrate Solution 1.62 mg/mL Anticipated Available Manufacturing 26/11/2025 risperidone Oral Liquid, solution 1 mg/mL Current Unavailable Manufacturing 26/11/2025 ropivacaine hydrochloride Injection, solution 2 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 26/11/2025 vinorelbine tartrate Injection, concentrated 13.85 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 26/11/2025 vinorelbine tartrate Injection, concentrated 13.85 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 26/11/2025 clonidine hydrochloride Tablet, uncoated 150 microgram Anticipated Available Manufacturing 26/11/2025 methylphenidate hydrochloride Capsule, modified release 20 mg Current Limited Availability Manufacturing 26/11/2025 methylphenidate hydrochloride Capsule, modified release 30 mg Current Limited Availability Manufacturing 26/11/2025 flecainide acetate Injection, solution 10 mg/mL Resolved Available Transport / Logistic issues / Storage capacity issues 25/11/2025 lidocaine hydrochloride Gel 20 mg/g Resolved Available Manufacturing 25/11/2025 medronic acid Injection, powder for 10 mg Current Unavailable Manufacturing 25/11/2025 sodium fluoride Injection, concentrated 1 mg/mL Current Unavailable Manufacturing 25/11/2025 phenoxymethylpenicillin potassium Tablet, film coated 560 mg Resolved Available Manufacturing 25/11/2025 armodafinil Tablet, uncoated 150 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 25/11/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Unexpected increase in consumer demand 25/11/2025 enalapril maleate Tablet 5 mg Anticipated Available Manufacturing 24/11/2025 phenobarbital Tablet, uncoated 30 mg Current Unavailable Manufacturing 24/11/2025 hydrochlorothiazide~candesartan cilexetil Tablet, uncoated 12.5 mg~16 mg Anticipated Available Manufacturing 24/11/2025 lansoprazole Tablet, orally disintegrating 15 mg Current Unavailable Manufacturing 24/11/2025 lansoprazole Tablet, orally disintegrating 30 mg Current Unavailable Manufacturing 24/11/2025 tranexamic acid Tablet, film coated 500 mg Current Unavailable Manufacturing 24/11/2025 nizatidine Capsule, hard 150 mg Current Unavailable Manufacturing 24/11/2025 metformin hydrochloride Tablet, film coated 1000 mg Resolved Available Unexpected increase in consumer demand 24/11/2025 ondansetron hydrochloride dihydrate Tablet, film coated 9.972 mg Anticipated Available Manufacturing 24/11/2025 fenofibrate Tablet, film coated 145 mg Anticipated Available Manufacturing 24/11/2025 escitalopram oxalate Tablet, film coated 12.74 mg Resolved Available Commercial Changes / Commercial viability 24/11/2025 escitalopram oxalate Tablet, film coated 25.47 mg Resolved Available Manufacturing 24/11/2025 eplerenone Tablet, film coated 25 mg Current Limited Availability Manufacturing 24/11/2025 Rabies virus Injection, powder for 2.5 IU Resolved Available Unexpected increase in consumer demand 24/11/2025 metaraminol tartrate Injection, solution 19 mg Current Unavailable Manufacturing 24/11/2025 Tocilizumab Injection, solution 162 mg Resolved Available Manufacturing 24/11/2025 lanreotide acetate Injection, solution 66.67 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 24/11/2025 hydrocortisone hydrogen succinate Injection, powder for 127.6 mg Current Limited Availability Manufacturing 24/11/2025 mupirocin Ointment 20 mg/g Current Unavailable Manufacturing 24/11/2025 labetalol hydrochloride Tablet, film coated 100 mg Current Unavailable Manufacturing 24/11/2025 flunitrazepam Tablet, film coated 1 mg Current Limited Availability Manufacturing 24/11/2025 ciprofloxacin hydrochloride Tablet, film coated 582.21 mg Anticipated Available Manufacturing 24/11/2025 nizatidine Capsule, hard 300 mg Current Limited Availability Manufacturing 24/11/2025 - 2025.11.24
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated primidone Tablet, uncoated 250 mg Resolved Available Manufacturing 21/11/2025 trandolapril Capsule 2 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 21/11/2025 olanzapine pamoate monohydrate Injection, powder for 690 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 21/11/2025 nortriptyline Tablet, film coated 10 mg Anticipated Available Manufacturing 21/11/2025 lamotrigine Tablet, chewable 50 mg Current Unavailable Manufacturing 21/11/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Manufacturing 21/11/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Anticipated Available Manufacturing 21/11/2025 ondansetron hydrochloride dihydrate Tablet, film coated 4.986 mg Anticipated Available Manufacturing 21/11/2025 montelukast sodium Tablet, chewable 4.16 mg Current Unavailable Manufacturing 21/11/2025 lansoprazole Tablet, orally disintegrating 15 mg Current Limited Availability Unexpected increase in consumer demand 21/11/2025 quetiapine fumarate Tablet, modified release 345.39 mg Current Limited Availability Manufacturing 21/11/2025 quetiapine fumarate Tablet, modified release 460.52 mg Current Limited Availability Manufacturing 21/11/2025 quetiapine fumarate Tablet, modified release 345.39 mg Current Limited Availability Manufacturing 21/11/2025 mesalazine Granules, modified release 4 g Resolved Available Transport / Logistic issues / Storage capacity issues 21/11/2025 olmesartan medoxomil~hydrochlorothiazide Tablet 20 mg~12.5 mg Current Limited Availability Manufacturing 21/11/2025 acamprosate calcium Tablet, enteric coated 333 mg Anticipated Available Manufacturing 21/11/2025 latanoprost Eye Drops, solution .05 mg/mL Current Limited Availability Manufacturing 21/11/2025 latanoprost Eye Drops, solution .05 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 21/11/2025 benzathine benzylpenicillin tetrahydrate Injection, suspension 600000 USP Unit Current Unavailable Manufacturing 21/11/2025 ropinirole hydrochloride Tablet, film coated .285 mg Current Unavailable Manufacturing 21/11/2025 paroxetine hydrochloride Tablet, film coated 22.22 mg Anticipated Available Manufacturing 21/11/2025 lamotrigine Tablet, chewable 50 mg Current Limited Availability Manufacturing 21/11/2025 lamotrigine Tablet, chewable 100 mg Current Unavailable Manufacturing 21/11/2025 lamotrigine Tablet, chewable 200 mg Current Unavailable Manufacturing 21/11/2025 lamotrigine Tablet, chewable 200 mg Anticipated Available Manufacturing 21/11/2025 betahistine dihydrochloride Tablet 16 mg Current Limited Availability Manufacturing 21/11/2025 ondansetron hydrochloride dihydrate Tablet, film coated 4.986 mg Anticipated Available Manufacturing 21/11/2025 Alteplase Diluent, not applicable 10 mg Current Limited Availability Unexpected increase in consumer demand 21/11/2025 pramipexole dihydrochloride monohydrate Tablet, uncoated .125 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 21/11/2025 desferrioxamine mesilate Injection, powder for 2 g Anticipated Available Manufacturing 21/11/2025 linezolid Injection, solution 2 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 21/11/2025 ciprofloxacin hydrochloride Tablet, film coated 873.32 mg Current Unavailable Manufacturing 21/11/2025 lamotrigine Tablet, dispersible 100 mg Current Limited Availability Manufacturing 21/11/2025 rifampicin Oral Liquid 20 mg/mL Anticipated Available Unexpected increase in consumer demand 20/11/2025 imipramine hydrochloride Tablet, sugar coated 10 mg Anticipated Available Manufacturing 20/11/2025 lidocaine hydrochloride Gel 20 mg/g Current Limited Availability Manufacturing 20/11/2025 benzathine benzylpenicillin tetrahydrate Injection, suspension 1200000 USP Unit Current Emergency Supply Only Manufacturing 20/11/2025 ondansetron hydrochloride dihydrate Injection, solution 10 mg Current Limited Availability Manufacturing 20/11/2025 galantamine hydrobromide Capsule, modified release 20.512 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 20/11/2025 galantamine hydrobromide Capsule, modified release 30.768 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 20/11/2025 temozolomide Capsule, hard 5 mg Current Limited Availability Manufacturing 20/11/2025 Alteplase Injection, powder for 50 mg Resolved Available Unexpected increase in consumer demand 20/11/2025 tobramycin Capsule, hard 28 mg Current Emergency Supply Only Manufacturing 20/11/2025 desvenlafaxine Tablet, modified release 100 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 20/11/2025 desvenlafaxine Tablet, modified release 50 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 20/11/2025 entecavir Tablet, film coated .5 mg Current Unavailable Manufacturing 20/11/2025 entecavir Tablet, film coated 1 mg Current Limited Availability Manufacturing 20/11/2025 armodafinil Tablet, uncoated 250 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 20/11/2025 rifampicin Capsule 150 mg Current Emergency Supply Only Manufacturing 20/11/2025 rifampicin Capsule 300 mg Current Limited Availability Manufacturing 20/11/2025 atomoxetine hydrochloride Capsule, hard 20.57 mg Anticipated Available Manufacturing 20/11/2025 hydroxocobalamin acetate Injection, solution 1.044 mg Anticipated Available Unexpected increase in consumer demand 20/11/2025 doxepin hydrochloride Capsule, hard 11.3 mg Current Limited Availability Manufacturing 20/11/2025 levodopa~carbidopa monohydrate Tablet, uncoated 100 mg~27 mg Resolved Available Manufacturing 20/11/2025 deferasirox Tablet, film coated 90 mg Current Limited Availability Manufacturing 20/11/2025 deferasirox Tablet, film coated 360 mg Current Unavailable Manufacturing 20/11/2025 escitalopram oxalate Tablet, film coated 25.548 mg Current Limited Availability Manufacturing 20/11/2025 ropivacaine hydrochloride Injection, solution 7.5 mg/mL Current Limited Availability Manufacturing 20/11/2025 ropivacaine hydrochloride Injection, solution 7.5 mg/mL Current Unavailable Manufacturing 20/11/2025 ropivacaine hydrochloride Injection, solution 2 mg/mL Anticipated Available Manufacturing 20/11/2025 olanzapine Tablet, film coated 5 mg Resolved Available Transport / Logistic issues / Storage capacity issues 20/11/2025 dosulepin hydrochloride Tablet, film coated 75 mg Current Limited Availability Manufacturing 20/11/2025 olanzapine Wafer 5 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 20/11/2025 risperidone Injection, modified release 50 mg Current Limited Availability Manufacturing 20/11/2025 nizatidine Capsule 300 mg Current Limited Availability Manufacturing 20/11/2025 perindopril erbumine~indapamide hemihydrate Tablet, uncoated 4 mg~1.25 mg Discontinued Unavailable Commercial Changes / Commercial viability 20/11/2025 sertraline hydrochloride Tablet, film coated 55.96 mg Resolved Available Manufacturing 19/11/2025 minoxidil Tablet, uncoated 10 mg Current Limited Availability Manufacturing 19/11/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Manufacturing 19/11/2025 pregabalin Capsule, hard 25 mg Current Limited Availability Manufacturing 19/11/2025 hydrochlorothiazide~olmesartan medoxomil Tablet 12.5 mg~40 mg Current Limited Availability Manufacturing 19/11/2025 sacubitril~valsartan Tablet, film coated 97.2 mg~102.8 mg Current Unavailable Manufacturing 19/11/2025 tetrabenazine Tablet, uncoated 25 mg Current Unavailable Manufacturing 19/11/2025 chlorhexidine gluconate~cetrimide Solution, irrigation 15 mg~150 mg Anticipated Available Manufacturing 19/11/2025 chlorhexidine gluconate~cetrimide Solution, irrigation 4.5 mg~45 mg Anticipated Available Manufacturing 19/11/2025 betiatide Injection, powder for 1 mg Current Unavailable Manufacturing 18/11/2025 phenytoin sodium Injection, solution 250 mg Current Limited Availability Manufacturing 18/11/2025 phenytoin sodium Injection, solution 100 mg Current Unavailable Manufacturing 18/11/2025 olanzapine Tablet, orally disintegrating 5 mg Current Unavailable Manufacturing 18/11/2025 ropivacaine hydrochloride Injection, solution 2 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 18/11/2025 ropivacaine hydrochloride Injection, solution 2 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 18/11/2025 atorvastatin calcium trihydrate~amlodipine besilate Tablet, film coated 43.376 mg~6.94 mg Resolved Available Manufacturing 18/11/2025 hydromorphone hydrochloride Injection, solution 10 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 18/11/2025 Tocilizumab Injection, solution 162 mg Anticipated Available Manufacturing 18/11/2025 phenytoin sodium Injection, solution 100 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 18/11/2025 phenytoin sodium Injection, solution 250 mg Current Limited Availability Manufacturing 18/11/2025 dinoprostone Gel .3333 mg/g Current Emergency Supply Only Manufacturing 18/11/2025 dinoprostone Gel .6667 mg/g Current Emergency Supply Only Manufacturing 18/11/2025 flecainide acetate Injection, solution 10 mg/mL Current Unavailable Transport / Logistic issues / Storage capacity issues 17/11/2025 prazosin hydrochloride Tablet, uncoated 1.095 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 17/11/2025 prazosin hydrochloride Tablet, uncoated 5.476 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 17/11/2025 tobramycin Injection, solution 80 mg Anticipated Available Manufacturing 17/11/2025 mupirocin Ointment 22 mg/g Resolved Available Unexpected increase in consumer demand 17/11/2025 glimepiride Tablet, uncoated 1 mg Current Unavailable Manufacturing 17/11/2025 risperidone Tablet, film coated 3 mg Current Unavailable Manufacturing 17/11/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Manufacturing 17/11/2025 galantamine hydrobromide Capsule, modified release 10.252 mg Current Unavailable Manufacturing 17/11/2025 galantamine hydrobromide Capsule, modified release 10.252 mg Current Unavailable Manufacturing 17/11/2025 galantamine hydrobromide Capsule, modified release 20.504 mg Current Unavailable Manufacturing 17/11/2025 galantamine hydrobromide Capsule, modified release 20.504 mg Current Unavailable Manufacturing 17/11/2025 tranexamic acid Injection, solution 1000 mg Current Unavailable Commercial Changes / Commercial viability 17/11/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Resolved Available Manufacturing 17/11/2025 flecainide acetate Tablet, uncoated 50 mg Anticipated Available Manufacturing 17/11/2025 bimatoprost Eye Drops .3 mg/mL Current Unavailable Manufacturing 17/11/2025 anastrozole Tablet, film coated 1 mg Resolved Available Manufacturing 17/11/2025 tenofovir disoproxil maleate~efavirenz~emtricitabine Tablet, film coated 300 mg~600 mg~200 mg Current Unavailable Manufacturing 17/11/2025 escitalopram oxalate Tablet, film coated 12.74 mg Current Unavailable Commercial Changes / Commercial viability 17/11/2025 escitalopram oxalate Tablet, film coated 25.47 mg Current Limited Availability Manufacturing 17/11/2025 ambrisentan Tablet, film coated 10 mg Current Limited Availability Manufacturing 17/11/2025 risperidone Tablet, film coated 1 mg Anticipated Available Manufacturing 17/11/2025 dimethyl fumarate Capsule, enteric 240 mg Anticipated Available Manufacturing 17/11/2025 fingolimod hydrochloride Capsule 560 microgram Current Limited Availability Manufacturing 17/11/2025 oseltamivir phosphate Capsule, hard 98.524 mg Current Limited Availability Manufacturing 17/11/2025 lamotrigine Tablet, chewable 100 mg Current Unavailable Manufacturing 17/11/2025 rivaroxaban Tablet, film coated 10 mg Resolved Available Manufacturing 17/11/2025 rivaroxaban Tablet, film coated 15 mg Current Limited Availability Manufacturing 17/11/2025 sitagliptin hydrochloride monohydrate~metformin hydrochloride Tablet, modified release 56.685 mg~1000 mg Current Unavailable Manufacturing 17/11/2025 nitrofurantoin Capsule, hard 50 mg Anticipated Available Manufacturing 17/11/2025 patisiran sodium Injection, concentrated 10.5 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 17/11/2025 bleomycin sulfate Injection, powder for 15000 IU Current Emergency Supply Only Manufacturing 17/11/2025 bumetanide Tablet, uncoated 1 mg Resolved Available Manufacturing 17/11/2025 ethinylestradiol~norethisterone Tablet, uncoated 36 microgram~500 microgram Current Limited Availability Manufacturing 17/11/2025 voriconazole Injection, powder for 200 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 17/11/2025 galantamine hydrobromide~galantamine Capsule, modified release 20.51 mg~16 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 17/11/2025 - 2025.11.18
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated atracurium besilate Injection, intravenous infusion 10 mg/mL Current Unavailable Manufacturing 14/11/2025 lamotrigine Tablet, chewable 100 mg Current Unavailable Manufacturing 14/11/2025 bisoprolol fumarate Tablet 5 mg Current Limited Availability Manufacturing 14/11/2025 bisoprolol fumarate Tablet 10 mg Current Limited Availability Manufacturing 14/11/2025 atorvastatin calcium trihydrate Tablet, film coated 21.69 mg Current Unavailable Manufacturing 14/11/2025 atorvastatin calcium trihydrate~amlodipine besilate Tablet, film coated 43.376 mg~13.88 mg Resolved Available Manufacturing 14/11/2025 quetiapine fumarate Tablet, modified release 345.39 mg Current Limited Availability Manufacturing 14/11/2025 linezolid Tablet, film coated 600 mg Current Unavailable Manufacturing 14/11/2025 amlodipine besilate~olmesartan medoxomil Tablet, film coated 6.935 mg~20 mg Anticipated Available Manufacturing 14/11/2025 pregabalin Capsule, hard 300 mg Resolved Available Manufacturing 14/11/2025 hydrochlorothiazide~olmesartan medoxomil~amlodipine besilate Tablet, film coated 12.5 mg~40 mg~13.9 mg Current Unavailable Manufacturing 14/11/2025 lamotrigine Tablet, chewable 50 mg Anticipated Available Manufacturing 14/11/2025 flecainide acetate Tablet 50 mg Resolved Available Manufacturing 14/11/2025 tofacitinib citrate Solution 1.62 mg/mL Anticipated Available Manufacturing 14/11/2025 mivacurium chloride Injection, solution 2.14 mg/mL Current Unavailable Manufacturing 14/11/2025 rifampicin Capsule, hard 300 mg Current Emergency Supply Only Manufacturing 14/11/2025 benzathine benzylpenicillin tetrahydrate Injection, suspension 1200000 USP Unit Current Emergency Supply Only Manufacturing 13/11/2025 ropivacaine hydrochloride Injection, solution 75 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 13/11/2025 escitalopram oxalate Tablet, film coated 12.774 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 13/11/2025 escitalopram oxalate Tablet, film coated 25.548 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 13/11/2025 acarbose Tablet 100 mg Resolved Available Manufacturing 13/11/2025 irbesartan Tablet, film coated 300 mg Anticipated Available Manufacturing 13/11/2025 irbesartan Tablet, film coated 150 mg Anticipated Available Manufacturing 13/11/2025 bimatoprost Eye Drops .3 mg/mL Anticipated Available Manufacturing 13/11/2025 escitalopram oxalate Tablet, film coated 12.774 mg Anticipated Available Manufacturing 13/11/2025 nitrofurantoin Capsule, hard 100 mg Current Unavailable Unexpected increase in consumer demand 13/11/2025 mitomycin Injection, powder for 20 mg Current Limited Availability Manufacturing 13/11/2025 tobramycin Injection, solution 40 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 13/11/2025 ephedrine sulfate Injection, solution 30 mg/mL Resolved Available Manufacturing 12/11/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Resolved Available Unexpected increase in consumer demand 12/11/2025 mesalazine Granules, modified release 4 g Current Limited Availability Transport / Logistic issues / Storage capacity issues 12/11/2025 levetiracetam Solution 100 mg/mL Current Limited Availability Manufacturing 12/11/2025 tranexamic acid Tablet, film coated 500 mg Current Limited Availability Manufacturing 12/11/2025 atorvastatin calcium trihydrate Tablet, film coated 86.76 mg Resolved Available Manufacturing 12/11/2025 metformin hydrochloride Tablet, film coated 1000 mg Current Unavailable Unexpected increase in consumer demand 12/11/2025 lacosamide Tablet, film coated 100 mg Current Limited Availability Manufacturing 12/11/2025 lacosamide Tablet, film coated 50 mg Current Limited Availability Manufacturing 12/11/2025 montelukast sodium Tablet, chewable 5.2 mg Current Unavailable Manufacturing 12/11/2025 isotretinoin Capsule, soft 10 mg Current Unavailable Manufacturing 12/11/2025 adrenaline (epinephrine) Injection, solution 500 microgram Current Unavailable Manufacturing 12/11/2025 daptomycin Injection, powder for 500 mg Current Unavailable Manufacturing 12/11/2025 daptomycin Inhalation, powder for 350 mg Current Unavailable Manufacturing 12/11/2025 spironolactone Tablet, film coated 25 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 12/11/2025 flunitrazepam Tablet, film coated 1 mg Current Limited Availability Manufacturing 12/11/2025 dienogest~ethinylestradiol Tablet, sugar coated 2 mg~.03 mg Discontinued Reduction in supply until supply is exhausted Manufacturing 11/11/2025 nortriptyline Tablet, film coated 10 mg Anticipated Available Manufacturing 11/11/2025 insulin Injection, suspension 100 IU/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 11/11/2025 insulin Injection, solution 100 IU/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 11/11/2025 doxylamine succinate Tablet, uncoated 25 mg Resolved Available Unexpected increase in consumer demand 11/11/2025 milrinone Injection, concentrated 10 mg Current Unavailable Manufacturing 11/11/2025 lamotrigine Tablet, uncoated 100 mg Current Limited Availability Manufacturing 11/11/2025 prasugrel Tablet, film coated 5 mg Current Unavailable Commercial Changes / Commercial viability 11/11/2025 insulin Injection, suspension 100 IU/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 11/11/2025 Insulin lispro Injection, solution 100 IU/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 11/11/2025 cisatracurium besilate Injection, solution 2.68 mg/mL Current Unavailable Manufacturing 11/11/2025 vinorelbine tartrate Injection, concentrated 13.85 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 11/11/2025 sertraline hydrochloride Tablet, film coated 55.96 mg Current Unavailable Manufacturing 10/11/2025 olanzapine pamoate monohydrate Injection, powder for 690 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 10/11/2025 bethanechol chloride Tablet, uncoated 10 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 10/11/2025 riluzole Tablet, film coated 50 mg Anticipated Available Manufacturing 10/11/2025 cyproterone acetate Tablet, uncoated 50 mg Current Unavailable Manufacturing 10/11/2025 cyproterone acetate Tablet, uncoated 100 mg Anticipated Available Manufacturing 10/11/2025 ambrisentan Tablet, film coated 10 mg Anticipated Available Manufacturing 10/11/2025 acamprosate calcium Tablet, enteric coated 333 mg Anticipated Available Manufacturing 10/11/2025 paroxetine hydrochloride Tablet, film coated 22.22 mg Anticipated Available Manufacturing 10/11/2025 hyoscine butylbromide Injection, solution 20 mg Resolved Available Manufacturing 10/11/2025 ondansetron hydrochloride dihydrate Tablet, film coated 4.986 mg Anticipated Available Manufacturing 10/11/2025 isotretinoin Capsule, soft 10 mg Anticipated Available Manufacturing 10/11/2025 rifampicin Capsule, hard 150 mg Current Limited Availability Manufacturing 10/11/2025 - 2025.11.10
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated betiatide Injection, powder for 1 mg Current Emergency Supply Only Manufacturing 7/11/2025 tobramycin Injection, solution 80 mg Anticipated Available Manufacturing 7/11/2025 primidone Tablet, uncoated 250 mg Current Emergency Supply Only Manufacturing 7/11/2025 trandolapril Capsule 2 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 7/11/2025 topiramate Tablet, film coated 25 mg Current Unavailable Manufacturing 7/11/2025 sodium lactate~magnesium chloride hexahydrate~glucose~sodium chloride~calcium chloride dihydrate Solution, irrigation 4.48 g/L~50.8 mg/L~15 g/L~5.38 g/L~183 mg/L Resolved Available Manufacturing 7/11/2025 glucose~sodium chloride~sodium lactate~magnesium chloride hexahydrate~calcium chloride dihydrate Solution, irrigation 25 g/L~5.38 g/L~4.48 g/L~50.8 mg/L~183 mg/L Resolved Available Manufacturing 7/11/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Manufacturing 7/11/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Manufacturing 7/11/2025 ondansetron hydrochloride dihydrate Tablet, film coated 4.986 mg Anticipated Available Manufacturing 7/11/2025 atorvastatin calcium trihydrate Tablet, film coated 43.38 mg Current Unavailable Manufacturing 7/11/2025 galantamine hydrobromide Capsule, modified release 20.504 mg Current Unavailable Manufacturing 7/11/2025 galantamine hydrobromide Capsule, modified release 30.756 mg Current Unavailable Manufacturing 7/11/2025 sumatriptan succinate Tablet, film coated 69.99 mg Current Limited Availability Manufacturing 7/11/2025 phenobarbital Tablet, uncoated 30 mg Current Unavailable Manufacturing 7/11/2025 carbidopa monohydrate~entacapone~levodopa Tablet, film coated 27 mg~200 mg~100 mg Current Limited Availability Unexpected increase in consumer demand 7/11/2025 levodopa~carbidopa monohydrate~entacapone Tablet, film coated 150 mg~40.5 mg~200 mg Current Unavailable Unexpected increase in consumer demand 7/11/2025 levodopa~carbidopa monohydrate~entacapone Tablet, film coated 200 mg~54.1 mg~200 mg Current Limited Availability Unexpected increase in consumer demand 7/11/2025 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Unexpected increase in consumer demand 7/11/2025 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in consumer demand 7/11/2025 mebeverine hydrochloride Tablet, film coated 135 mg Current Limited Availability Manufacturing 7/11/2025 latanoprost Eye Drops, solution .05 mg/mL Anticipated Available Manufacturing 7/11/2025 metaraminol tartrate Injection, solution 19 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 7/11/2025 aprepitant Capsule 165 mg Anticipated Available Manufacturing 7/11/2025 fingolimod hydrochloride Capsule 560 microgram Anticipated Available Manufacturing 7/11/2025 lamotrigine Tablet, chewable 100 mg Current Unavailable Manufacturing 7/11/2025 valsartan~sacubitril Tablet, film coated 51.4 mg~48.6 mg Current Unavailable Manufacturing 7/11/2025 sacubitril~valsartan Tablet, film coated 24.3 mg~25.7 mg Current Unavailable Manufacturing 7/11/2025 sitagliptin hydrochloride monohydrate~metformin hydrochloride Tablet, modified release 56.685 mg~1000 mg Current Limited Availability Manufacturing 7/11/2025 nitrofurantoin Capsule, hard 50 mg Anticipated Available Manufacturing 7/11/2025 naltrexone hydrochloride Tablet, film coated 50 mg Anticipated Available Manufacturing 7/11/2025 rivaroxaban Tablet, film coated 10 mg Resolved Available Manufacturing 7/11/2025 carbidopa monohydrate~levodopa Tablet, uncoated 26.9 mg~100 mg Resolved Available Manufacturing 7/11/2025 bumetanide Tablet, uncoated 1 mg Current Limited Availability Manufacturing 7/11/2025 diltiazem hydrochloride Capsule, modified release 360 mg Current Limited Availability Manufacturing 7/11/2025 magnesium chloride hexahydrate~calcium chloride dihydrate~sodium lactate~sodium chloride~icodextrin Solution, dialysis 51 mg/L~257 mg/L~4.5 g/L~5.4 g/L~75 g/L Resolved Available Manufacturing 7/11/2025 nizatidine Capsule, hard 300 mg Anticipated Available Manufacturing 7/11/2025 galantamine hydrobromide~galantamine Capsule, modified release 20.51 mg~16 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 7/11/2025 lamotrigine Tablet, dispersible 200 mg Current Limited Availability Manufacturing 7/11/2025 sodium amidotrizoate~amidotrizoate meglumine Oral Liquid, solution 100 mg/mL~660 mg/mL Discontinued Unavailable Seasonal depletion of stock 6/11/2025 live varicella vaccine Injection, powder for 2700 PFU/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 6/11/2025 minoxidil Tablet, uncoated 10 mg Anticipated Available Manufacturing 6/11/2025 ropivacaine hydrochloride Injection, solution 75 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 6/11/2025 Infliximab Injection, powder for 100 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 6/11/2025 montelukast sodium Tablet, chewable 4.16 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 6/11/2025 montelukast sodium Tablet, chewable 4.16 mg Current Unavailable Manufacturing 6/11/2025 verapamil hydrochloride Tablet, modified release 240 mg Current Limited Availability Manufacturing 5/11/2025 terbutaline sulfate Injection, solution .5 mg/mL Anticipated Available Manufacturing 5/11/2025 midazolam Injection, solution 5 mg/mL Resolved Available Manufacturing 5/11/2025 pantoprazole sodium sesquihydrate Tablet, enteric coated 45.4 mg Resolved Available Unexpected increase in consumer demand 5/11/2025 Alteplase Injection, powder for 50 mg Current Limited Availability Unexpected increase in consumer demand 5/11/2025 montelukast sodium Tablet, chewable 5.2 mg Resolved Available Manufacturing 5/11/2025 montelukast sodium Tablet, chewable 4.16 mg Current Unavailable Manufacturing 5/11/2025 amlodipine besilate~atorvastatin calcium trihydrate Tablet, film coated 13.88 mg~10.844 mg Current Unavailable Manufacturing 5/11/2025 mesalazine Granules, modified release 4 g Current Limited Availability Transport / Logistic issues / Storage capacity issues 5/11/2025 dabigatran etexilate mesilate Capsule, hard 172.95 mg Current Unavailable Manufacturing 5/11/2025 doxepin hydrochloride Capsule, hard 11.3 mg Anticipated Available Manufacturing 5/11/2025 midodrine hydrochloride Tablet 5 mg Current Unavailable Manufacturing 5/11/2025 larotrectinib sulfate Capsule, hard 30.7 mg Resolved Available Unexpected increase in consumer demand 5/11/2025 tenofovir disoproxil succinate~emtricitabine Tablet, film coated 300.6 mg~200 mg Current Unavailable Manufacturing 5/11/2025 flecainide acetate Tablet 50 mg Current Unavailable Manufacturing 5/11/2025 rivaroxaban Tablet, film coated 10 mg Anticipated Available Manufacturing 5/11/2025 rivaroxaban Tablet, film coated 15 mg Anticipated Available Manufacturing 5/11/2025 furosemide Injection, solution 20 mg Resolved Available Manufacturing 5/11/2025 ethinylestradiol~norethisterone Tablet, uncoated 36 microgram~500 microgram Current Limited Availability Manufacturing 5/11/2025 Alteplase Diluent, not applicable 10 mg Current Limited Availability Unexpected increase in consumer demand 5/11/2025 fluorouracil Injection, solution 50 mg/mL Resolved Available Unexpected increase in consumer demand 5/11/2025 flunitrazepam Tablet, film coated 1 mg Anticipated Available Manufacturing 5/11/2025 indometacin Suppository, moulded 100 mg Current Unavailable Manufacturing 4/11/2025 ropivacaine hydrochloride Injection, solution 10 mg/mL Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 4/11/2025 ropivacaine hydrochloride Injection, solution 7.5 mg/mL Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 4/11/2025 alfentanil hydrochloride Injection, solution 1.0876 mg Resolved Available Transport / Logistic issues / Storage capacity issues 4/11/2025 nystatin Oral Liquid, suspension 100000 IU/mL Current Unavailable Unexpected increase in consumer demand 4/11/2025 pregabalin Capsule, hard 25 mg Current Unavailable Manufacturing 4/11/2025 escitalopram oxalate Tablet, film coated 12.74 mg Current Unavailable Commercial Changes / Commercial viability 4/11/2025 escitalopram oxalate Tablet, film coated 25.47 mg Current Limited Availability Manufacturing 4/11/2025 lacosamide Tablet, film coated 150 mg Current Limited Availability Manufacturing 4/11/2025 montelukast sodium Tablet, chewable 5.2 mg Current Unavailable Manufacturing 4/11/2025 levothyroxine sodium Tablet, uncoated .05 mg Current Limited Availability Manufacturing 4/11/2025 ramipril Tablet, uncoated 1.25 mg Resolved Available Transport / Logistic issues / Storage capacity issues 4/11/2025 ramipril Tablet, uncoated 2.5 mg Current Limited Availability Manufacturing 4/11/2025 ropivacaine hydrochloride Injection, solution 7.5 mg/mL Current Limited Availability Manufacturing 4/11/2025 ropivacaine hydrochloride Injection, solution 7.5 mg/mL Current Unavailable Manufacturing 4/11/2025 sertraline hydrochloride Tablet, film coated 55.96 mg Current Unavailable Manufacturing 3/11/2025 clozapine Oral Liquid, suspension 50 mg/mL Current Unavailable Manufacturing 3/11/2025 risperidone Tablet 1 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 3/11/2025 lamivudine Tablet, film coated 300 mg Anticipated Available Manufacturing 3/11/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Anticipated Available Manufacturing 3/11/2025 olanzapine Tablet, orally disintegrating 10 mg Resolved Available Manufacturing 3/11/2025 montelukast sodium Tablet, chewable 4.16 mg Current Unavailable Manufacturing 3/11/2025 finasteride Tablet, film coated 5 mg Current Limited Availability Manufacturing 3/11/2025 risperidone Tablet, film coated .5 mg Resolved Available Manufacturing 3/11/2025 entecavir Tablet, film coated 1 mg Anticipated Available Manufacturing 3/11/2025 primaquine phosphate Tablet, uncoated 13.2 mg Current Emergency Supply Only Manufacturing 3/11/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Anticipated Available Manufacturing 3/11/2025 nicorandil Tablet, uncoated 20 mg Anticipated Available Manufacturing 3/11/2025 tobramycin Inhalation, conventional 60 mg/mL Anticipated Available Manufacturing 3/11/2025 phenytoin sodium Capsule, hard 30 mg Resolved Available Manufacturing 3/11/2025 bendamustine hydrochloride Injection, powder for 25 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 3/11/2025 finasteride Tablet, film coated 1 mg Anticipated Available Manufacturing 3/11/2025 Tocilizumab Injection, solution 162 mg Anticipated Available Manufacturing 3/11/2025 bleomycin sulfate Injection, powder for 15000 IU Anticipated Available Manufacturing 3/11/2025 pramipexole dihydrochloride monohydrate Tablet, uncoated 1 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 3/11/2025 pramipexole dihydrochloride monohydrate Tablet, uncoated .125 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 3/11/2025 - 2025.11.03
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated clozapine Oral Liquid, suspension 50 mg/mL Current Unavailable Manufacturing 3/11/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Anticipated Available Manufacturing 3/11/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Anticipated Available Manufacturing 3/11/2025 bleomycin sulfate Injection, powder for 15000 IU Anticipated Available Manufacturing 3/11/2025 pramipexole dihydrochloride monohydrate Tablet, uncoated 1 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 3/11/2025 pramipexole dihydrochloride monohydrate Tablet, uncoated .125 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 3/11/2025 saxagliptin~dapagliflozin propanediol monohydrate Tablet 5 mg~12.3 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 1/11/2025 dinoprostone Gel .3333 mg/g Anticipated Available Manufacturing 1/11/2025 betiatide Injection, powder for 1 mg Anticipated Available Manufacturing 31/10/2025 phenylephrine hydrochloride Injection, solution 10 mg/mL Anticipated Available Manufacturing 31/10/2025 phenoxymethylpenicillin potassium Oral Liquid, powder for 28.284 mg/mL Resolved Available Manufacturing 31/10/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Manufacturing 31/10/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Manufacturing 31/10/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 31/10/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Manufacturing 31/10/2025 bisoprolol fumarate Tablet 2.5 mg Resolved Available Manufacturing 31/10/2025 phenobarbital Tablet, uncoated 30 mg Current Limited Availability Manufacturing 31/10/2025 escitalopram oxalate Tablet, film coated 25.548 mg Current Limited Availability Manufacturing 31/10/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Unexpected increase in consumer demand 31/10/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Unexpected increase in consumer demand 31/10/2025 bimatoprost Eye Drops .3 mg/mL Current Unavailable Manufacturing 31/10/2025 linezolid Tablet, film coated 600 mg Current Unavailable Manufacturing 31/10/2025 irbesartan Tablet, film coated 300 mg Anticipated Available Manufacturing 31/10/2025 irbesartan Tablet, film coated 150 mg Anticipated Available Manufacturing 31/10/2025 tranexamic acid Tablet, film coated 500 mg Current Unavailable Manufacturing 31/10/2025 olmesartan medoxomil~amlodipine besilate Tablet, film coated 20 mg~6.935 mg Anticipated Available Manufacturing 31/10/2025 rasagiline mesilate Tablet 1.56 mg Current Limited Availability Manufacturing 31/10/2025 rasagiline mesilate Tablet 1.56 mg Current Unavailable Manufacturing 31/10/2025 ambrisentan Tablet, film coated 5 mg Current Limited Availability Manufacturing 31/10/2025 lorazepam Tablet 1 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 31/10/2025 hyoscine butylbromide Injection, solution 20 mg Current Limited Availability Manufacturing 31/10/2025 daptomycin Injection, powder for 500 mg Current Limited Availability Manufacturing 31/10/2025 fentanyl citrate Injection, solution 785 microgram Resolved Available Manufacturing 31/10/2025 famciclovir Tablet, film coated 250 mg Resolved Available Manufacturing 31/10/2025 famciclovir Tablet, film coated 500 mg Resolved Available Manufacturing 31/10/2025 lidocaine hydrochloride monohydrate Injection, solution 10 mg/mL Resolved Available Manufacturing 31/10/2025 lidocaine hydrochloride monohydrate Injection, solution 10 mg/mL Current Limited Availability Manufacturing 31/10/2025 pramipexole dihydrochloride monohydrate Tablet, uncoated .25 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 31/10/2025 lamotrigine Tablet, dispersible 200 mg Anticipated Available Manufacturing 31/10/2025 rifampicin Oral Liquid 20 mg/mL Anticipated Available Unexpected increase in consumer demand 30/10/2025 galantamine hydrobromide Capsule, modified release 20.512 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 30/10/2025 mesalazine Tablet, modified release 1 g Resolved Available Transport / Logistic issues / Storage capacity issues 30/10/2025 lansoprazole Capsule, enteric 30 mg Current Limited Availability Manufacturing 30/10/2025 ondansetron hydrochloride dihydrate Tablet, film coated 9.972 mg Current Limited Availability Manufacturing 30/10/2025 metronidazole Tablet, uncoated 400 mg Current Limited Availability Manufacturing 30/10/2025 naproxen Oral Liquid, suspension 25 mg/mL Resolved Available Manufacturing 30/10/2025 risperidone Tablet, film coated 3 mg Current Limited Availability Manufacturing 30/10/2025 quetiapine fumarate Tablet, modified release 345.39 mg Anticipated Available Manufacturing 30/10/2025 pramipexole dihydrochloride monohydrate Tablet, modified release .75 mg Resolved Available Manufacturing 30/10/2025 pramipexole dihydrochloride monohydrate Tablet, modified release .375 mg Resolved Available Manufacturing 30/10/2025 pramipexole dihydrochloride monohydrate Tablet, modified release 1.5 mg Resolved Available Manufacturing 30/10/2025 pramipexole dihydrochloride monohydrate Tablet, modified release 2.25 mg Resolved Available Manufacturing 30/10/2025 hydrochlorothiazide~irbesartan Tablet, film coated 12.5 mg~300 mg Resolved Available Manufacturing 30/10/2025 atenolol Tablet, film coated 50 mg Resolved Available Manufacturing 30/10/2025 latanoprost Eye Drops, solution .05 mg/mL Anticipated Available Manufacturing 30/10/2025 erlotinib hydrochloride Tablet, film coated 27.32 mg Current Unavailable Unexpected increase in consumer demand 30/10/2025 carvedilol Tablet, film coated 6.25 mg Resolved Available Manufacturing 30/10/2025 thiotepa Injection, powder for 15 mg Current Unavailable Commercial Changes / Commercial viability 30/10/2025 thiotepa Injection, powder for 100 mg Current Unavailable Commercial Changes / Commercial viability 30/10/2025 thiotepa Injection, powder for 400 mg Current Unavailable Commercial Changes / Commercial viability 30/10/2025 Teriparatide Injection, solution .25 mg/mL Resolved Available Unexpected increase in demand due to other sponsors unable to supply 30/10/2025 phenytoin sodium Injection, solution 250 mg Current Limited Availability Manufacturing 30/10/2025 mianserin hydrochloride Tablet, film coated 20 mg Current Limited Availability Manufacturing 30/10/2025 methyldopa sesquihydrate Tablet, film coated 283 mg Current Limited Availability Manufacturing 30/10/2025 pamidronate disodium Injection, concentrated 3 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 30/10/2025 nizatidine Capsule 300 mg Anticipated Available Manufacturing 30/10/2025 simvastatin Tablet, film coated 5 mg Anticipated Available Manufacturing 30/10/2025 verapamil hydrochloride~trandolapril Tablet, film coated 240 mg~4 mg Resolved Available Manufacturing 29/10/2025 calcium polystyrene sulfonate Powder 999.3 mg/g Anticipated Available Manufacturing 29/10/2025 risperidone Tablet, film coated 1 mg Resolved Available Manufacturing 29/10/2025 pentetic acid Injection, powder for 5 mg Current Unavailable Manufacturing 29/10/2025 medronic acid Injection, powder for 10 mg Current Unavailable Manufacturing 29/10/2025 sildenafil citrate Tablet, uncoated 35.1 mg Resolved Available Manufacturing 29/10/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 29/10/2025 ceftazidime pentahydrate Injection, powder for 2.328 g Current Limited Availability Manufacturing 29/10/2025 methylphenidate hydrochloride Capsule, modified release 10 mg Current Limited Availability Manufacturing 29/10/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.9 mg Current Unavailable Unexpected increase in consumer demand 29/10/2025 temozolomide Capsule, hard 5 mg Current Limited Availability Manufacturing 29/10/2025 sodium nitroprusside Injection, solution 50 mg Anticipated Available Manufacturing 29/10/2025 tobramycin Capsule, hard 28 mg Anticipated Available Manufacturing 29/10/2025 lansoprazole Tablet, orally disintegrating 30 mg Current Limited Availability Manufacturing 29/10/2025 atorvastatin calcium trihydrate~amlodipine besilate Tablet, film coated 43.376 mg~13.88 mg Current Limited Availability Manufacturing 29/10/2025 phenoxymethylpenicillin potassium Tablet, film coated 560 mg Current Limited Availability Manufacturing 29/10/2025 rosuvastatin calcium Tablet, film coated 41.68 mg Current Unavailable Manufacturing 29/10/2025 pregabalin Capsule, hard 75 mg Resolved Available Manufacturing 29/10/2025 methylphenidate hydrochloride Capsule, modified release 60 mg Current Limited Availability Manufacturing 29/10/2025 mesalazine Tablet, enteric coated 800 mg Resolved Available Transport / Logistic issues / Storage capacity issues 29/10/2025 hydrocortisone Tablet, uncoated 4 mg Current Limited Availability Manufacturing 29/10/2025 tadalafil Tablet, film coated 5 mg Resolved Available Manufacturing 29/10/2025 risperidone Tablet, film coated .5 mg Anticipated Available Commercial Changes / Commercial viability 29/10/2025 risperidone Tablet, film coated 1 mg Current Unavailable Commercial Changes / Commercial viability 29/10/2025 risperidone Tablet, film coated 2 mg Current Unavailable Commercial Changes / Commercial viability 29/10/2025 risperidone Tablet, film coated 3 mg Current Unavailable Commercial Changes / Commercial viability 29/10/2025 risperidone Tablet, film coated 4 mg Current Unavailable Commercial Changes / Commercial viability 29/10/2025 fluorouracil Injection, solution 50 mg/mL Resolved Available Unexpected increase in consumer demand 29/10/2025 benzathine benzylpenicillin tetrahydrate Injection, suspension 600000 USP Unit Current Unavailable Manufacturing 29/10/2025 lurasidone hydrochloride Tablet, film coated 40 mg Resolved Available Manufacturing 29/10/2025 lurasidone hydrochloride Tablet, film coated 80 mg Resolved Available Manufacturing 29/10/2025 amiodarone hydrochloride Tablet, uncoated 100 mg Resolved Available Manufacturing 29/10/2025 spironolactone Tablet, uncoated 100 mg Resolved Available Manufacturing 29/10/2025 lenalidomide Capsule 5 mg Resolved Available Manufacturing 29/10/2025 sugammadex sodium Injection, solution 217.6 mg Resolved Available Manufacturing 29/10/2025 hydrocortisone hydrogen succinate Injection, powder for 127.6 mg Anticipated Available Manufacturing 29/10/2025 levothyroxine sodium Tablet 50 microgram Resolved Available Unexpected increase in consumer demand 29/10/2025 levothyroxine sodium Tablet 100 microgram Resolved Available Unexpected increase in consumer demand 29/10/2025 sodium chloride Injection, intravenous infusion 9 g/L Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 29/10/2025 dorzolamide hydrochloride Eye Drops, solution 22.26 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 29/10/2025 labetalol hydrochloride Tablet, film coated 100 mg Current Unavailable Manufacturing 29/10/2025 methylphenidate hydrochloride Capsule, modified release 20 mg Current Unavailable Manufacturing 29/10/2025 methylphenidate hydrochloride Capsule, modified release 30 mg Current Unavailable Manufacturing 29/10/2025 methylphenidate hydrochloride Capsule, modified release 40 mg Current Unavailable Manufacturing 29/10/2025 amoxicillin sodium Injection, powder for 1060 mg Resolved Available Manufacturing 29/10/2025 Rubella virus~Measles virus~live varicella vaccine~Mumps virus Injection, powder for 1000 CCID50~1000 CCID50~1995 PFU~25119 CCID50 Resolved Available Manufacturing 28/10/2025 prazosin hydrochloride Tablet, uncoated 2.19 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 28/10/2025 prazosin hydrochloride Tablet, uncoated 5.476 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 28/10/2025 salbutamol sulfate Inhalation, conventional 6 mg Current Unavailable Manufacturing 28/10/2025 stannous chloride~etifenin Injection, powder for .42 mg~20 mg Current Unavailable Manufacturing 28/10/2025 Somatropin Injection, powder for 12 mg/mL Current Limited Availability Unexpected increase in consumer demand 28/10/2025 hydrocortisone sodium succinate Injection, powder for 134 mg Resolved Available Manufacturing 28/10/2025 enalapril maleate Tablet 5 mg Current Limited Availability Manufacturing 28/10/2025 alfentanil hydrochloride Injection, solution 1.0876 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 28/10/2025 doxylamine succinate Tablet, uncoated 25 mg Current Limited Availability Unexpected increase in consumer demand 28/10/2025 quetiapine fumarate Tablet, modified release 57.5 mg Anticipated Available Unexpected increase in consumer demand 28/10/2025 peramivir Injection, concentrated 10 mg/mL Anticipated Available Commercial Changes / Commercial viability 28/10/2025 topotecan hydrochloride Injection, concentrated 4.346 mg Current Limited Availability Unexpected increase in consumer demand 28/10/2025 stannous chloride dihydrate Injection, powder for 19.2 microgram/mL Resolved Available Manufacturing 28/10/2025 Interferon gamma1b Injection, solution 4 million IU/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 28/10/2025 risperidone Injection, modified release 50 mg Anticipated Available Manufacturing 28/10/2025 Insulin glulisine Injection, solution 3.49 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 28/10/2025 lidocaine hydrochloride Injection, solution 10 mg/mL Resolved Available Manufacturing 27/10/2025 simvastatin~ezetimibe Tablet 80 mg~10 mg Anticipated Available Manufacturing 27/10/2025 ezetimibe~simvastatin Tablet 10 mg~40 mg Anticipated Available Manufacturing 27/10/2025 donepezil hydrochloride Tablet, film coated 5 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 27/10/2025 cyproterone acetate Tablet, uncoated 100 mg Anticipated Available Manufacturing 27/10/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Manufacturing 27/10/2025 atorvastatin calcium trihydrate~ezetimibe Tablet, film coated 10.341 mg~10 mg Resolved Available Manufacturing 27/10/2025 emtricitabine~tenofovir disoproxil succinate Tablet, film coated 200 mg~300.6 mg Current Limited Availability Manufacturing 27/10/2025 pentamidine isetionate Injection, powder for 300 mg Anticipated Available Manufacturing 27/10/2025 flecainide acetate Tablet 50 mg Current Unavailable Manufacturing 27/10/2025 GluureaLys(ahx)hbedCC Injection, powder for 25 microgram Current Unavailable Manufacturing 27/10/2025 GluureaLys(ahx)hbedCC Injection, powder for 25 microgram Current Unavailable Manufacturing 27/10/2025 iotroxate meglumine Injection, solution 105.46 mg/mL Resolved Available Transport / Logistic issues / Storage capacity issues 27/10/2025 galantamine hydrobromide~galantamine Capsule, modified release 20.51 mg~16 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 27/10/2025 - 2025.10.27
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated prazosin hydrochloride Tablet, uncoated 1.095 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 24/10/2025 prazosin hydrochloride Tablet, uncoated 2.19 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 24/10/2025 prazosin hydrochloride Tablet, uncoated 5.476 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 24/10/2025 ramipril Tablet, uncoated 1.25 mg Resolved Available Manufacturing 24/10/2025 trandolapril Capsule 2 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 24/10/2025 tranexamic acid Tablet, film coated 500 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 24/10/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 24/10/2025 risperidone Tablet, film coated 2 mg Current Limited Availability Manufacturing 24/10/2025 bisoprolol fumarate Tablet 2.5 mg Current Unavailable Manufacturing 24/10/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.9 mg Current Limited Availability Unexpected increase in consumer demand 24/10/2025 exemestane Tablet, sugar coated 25 mg Anticipated Available Manufacturing 24/10/2025 indapamide hemihydrate Tablet, sugar coated 2.5 mg Current Limited Availability Manufacturing 24/10/2025 ropivacaine hydrochloride Injection, solution 200 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 24/10/2025 clopidogrel besilate Tablet, film coated 112.1 mg Current Unavailable Manufacturing 24/10/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Unexpected increase in consumer demand 24/10/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Unexpected increase in consumer demand 24/10/2025 rosuvastatin calcium Tablet, film coated 10.42 mg Current Unavailable Manufacturing 24/10/2025 pregabalin Capsule, hard 150 mg Current Limited Availability Unexpected increase in consumer demand 24/10/2025 levetiracetam Solution 100 mg/mL Resolved Available Manufacturing 24/10/2025 clonidine hydrochloride Tablet 100 microgram Resolved Available Unexpected increase in consumer demand 24/10/2025 tranexamic acid Tablet, film coated 500 mg Current Limited Availability Manufacturing 24/10/2025 tranexamic acid Tablet, film coated 500 mg Current Unavailable Manufacturing 24/10/2025 cyproterone acetate Tablet, uncoated 50 mg Current Unavailable Manufacturing 24/10/2025 hydrocortisone Tablet, uncoated 4 mg Current Limited Availability Manufacturing 24/10/2025 nizatidine Capsule, hard 150 mg Resolved Available Manufacturing 24/10/2025 nizatidine Capsule, hard 150 mg Current Unavailable Manufacturing 24/10/2025 rasagiline mesilate Tablet 1.56 mg Anticipated Available Manufacturing 24/10/2025 ambrisentan Tablet, film coated 10 mg Anticipated Available Manufacturing 24/10/2025 teriflunomide Tablet, film coated 14 mg Current Limited Availability Manufacturing 24/10/2025 gabapentin Tablet, film coated 600 mg Anticipated Available Manufacturing 24/10/2025 hydrochlorothiazide~amlodipine besilate~olmesartan medoxomil Tablet, film coated 12.5 mg~13.9 mg~40 mg Current Limited Availability Manufacturing 24/10/2025 paclitaxel Injection, powder for 100 mg Current Limited Availability Manufacturing 24/10/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 24/10/2025 tranexamic acid Tablet, film coated 500 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 24/10/2025 ethinylestradiol~norethisterone Tablet, uncoated 36 microgram~500 microgram Anticipated Available Manufacturing 24/10/2025 pramipexole dihydrochloride monohydrate Tablet, uncoated 1 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 24/10/2025 prazosin hydrochloride Tablet, uncoated 1.1 mg Current Unavailable Manufacturing 24/10/2025 prazosin hydrochloride Tablet, uncoated 2.2 mg Current Unavailable Manufacturing 24/10/2025 prazosin hydrochloride Tablet, uncoated 5.5 mg Current Unavailable Manufacturing 24/10/2025 trandolapril Capsule 4 mg Resolved Available Manufacturing 24/10/2025 dinoprostone Gel .6667 mg/g Anticipated Available Manufacturing 24/10/2025 risperidone Tablet, film coated 2 mg Resolved Available Manufacturing 23/10/2025 topiramate Tablet, film coated 25 mg Current Unavailable Manufacturing 23/10/2025 olanzapine Tablet, orally disintegrating 20 mg Resolved Available Manufacturing 23/10/2025 phenoxymethylpenicillin potassium Oral Liquid, powder for 28.284 mg/mL Current Unavailable Manufacturing 23/10/2025 levetiracetam Tablet, film coated 500 mg Current Unavailable Manufacturing 23/10/2025 levetiracetam Tablet, film coated 1000 mg Current Unavailable Manufacturing 23/10/2025 olanzapine Tablet, orally disintegrating 10 mg Current Unavailable Manufacturing 23/10/2025 olanzapine Tablet, orally disintegrating 5 mg Current Unavailable Manufacturing 23/10/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Current Limited Availability Unexpected increase in consumer demand 23/10/2025 lansoprazole Tablet, orally disintegrating 30 mg Current Limited Availability Manufacturing 23/10/2025 sildenafil citrate Tablet, film coated 28.1 mg Current Unavailable Manufacturing 23/10/2025 isotretinoin Capsule, soft 10 mg Current Unavailable Manufacturing 23/10/2025 isotretinoin Capsule, soft 20 mg Current Unavailable Manufacturing 23/10/2025 ezetimibe~simvastatin Tablet 10 mg~10 mg Current Unavailable Manufacturing 23/10/2025 ezetimibe~simvastatin Tablet 10 mg~20 mg Current Unavailable Manufacturing 23/10/2025 rosuvastatin calcium Tablet, film coated 20.84 mg Current Unavailable Unexpected increase in consumer demand 23/10/2025 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in consumer demand 23/10/2025 irbesartan Tablet, film coated 150 mg Resolved Available Manufacturing 23/10/2025 cyproterone acetate Tablet, uncoated 100 mg Anticipated Available Manufacturing 23/10/2025 atorvastatin calcium trihydrate Tablet, film coated 86.76 mg Current Unavailable Manufacturing 23/10/2025 efavirenz~tenofovir disoproxil maleate~emtricitabine Tablet, film coated 600 mg~300 mg~200 mg Current Unavailable Manufacturing 23/10/2025 olmesartan medoxomil~hydrochlorothiazide Tablet 20 mg~12.5 mg Anticipated Available Manufacturing 23/10/2025 bimatoprost Eye Drops .3 mg/mL Anticipated Available Manufacturing 23/10/2025 nitrofurantoin Capsule, hard 100 mg Resolved Available Manufacturing 23/10/2025 Teriparatide Injection, solution .25 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 23/10/2025 naltrexone hydrochloride Tablet, film coated 50 mg Anticipated Available Manufacturing 23/10/2025 levothyroxine sodium Tablet 200 microgram Current Unavailable Unexpected increase in consumer demand 23/10/2025 rivaroxaban Tablet, film coated 10 mg Anticipated Available Manufacturing 23/10/2025 tamoxifen citrate Tablet, uncoated 15.2 mg Current Unavailable Manufacturing 23/10/2025 tamoxifen citrate Tablet, uncoated 30.4 mg Current Unavailable Manufacturing 23/10/2025 isotretinoin Capsule, soft 20 mg Current Unavailable Manufacturing 23/10/2025 isotretinoin Capsule, soft 10 mg Anticipated Available Manufacturing 23/10/2025 mupirocin Ointment 20 mg/g Current Unavailable Manufacturing 23/10/2025 lidocaine hydrochloride Injection, solution 10 mg/mL Resolved Available Manufacturing 23/10/2025 ropivacaine hydrochloride Injection, solution 10 mg/mL Resolved Available Manufacturing 23/10/2025 phenylephrine hydrochloride Injection, solution 10 mg/mL Anticipated Available Manufacturing 22/10/2025 galantamine hydrobromide Capsule, modified release 30.768 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 22/10/2025 mycophenolate mofetil Tablet, film coated 500 mg Current Limited Availability Manufacturing 22/10/2025 letrozole Tablet, film coated 2.5 mg Current Unavailable Manufacturing 22/10/2025 atorvastatin calcium trihydrate~amlodipine besilate Tablet, film coated 43.376 mg~6.94 mg Current Unavailable Manufacturing 22/10/2025 atorvastatin calcium trihydrate~amlodipine besilate Tablet, film coated 10.844 mg~13.88 mg Current Unavailable Manufacturing 22/10/2025 milrinone Injection, concentrated 10 mg Current Unavailable Manufacturing 22/10/2025 fingolimod hydrochloride Capsule 560 microgram Anticipated Available Manufacturing 22/10/2025 phenytoin sodium Injection, solution 250 mg Current Limited Availability Manufacturing 22/10/2025 bromazepam Tablet, uncoated 6 mg Resolved Available Transport / Logistic issues / Storage capacity issues 22/10/2025 bisoprolol fumarate Tablet 2.5 mg Current Unavailable Manufacturing 21/10/2025 ropivacaine hydrochloride Injection, solution 10 mg/mL Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 21/10/2025 clindamycin hydrochloride Capsule, hard 162.87 mg Anticipated Available Manufacturing 21/10/2025 mesalazine Tablet, enteric coated 800 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 21/10/2025 acamprosate calcium Tablet, enteric coated 333 mg Anticipated Available Manufacturing 21/10/2025 moxonidine Tablet, film coated 400 microgram Current Limited Availability Manufacturing 21/10/2025 paroxetine hydrochloride Tablet, film coated 22.22 mg Anticipated Available Manufacturing 21/10/2025 carvedilol Tablet, film coated 6.25 mg Anticipated Available Manufacturing 21/10/2025 lamotrigine Tablet, chewable 100 mg Current Limited Availability Manufacturing 21/10/2025 lamotrigine Tablet, chewable 200 mg Anticipated Available Manufacturing 21/10/2025 ondansetron hydrochloride dihydrate Tablet, film coated 4.986 mg Anticipated Available Manufacturing 21/10/2025 famciclovir Tablet, film coated 250 mg Current Unavailable Manufacturing 21/10/2025 famciclovir Tablet, film coated 500 mg Current Unavailable Manufacturing 21/10/2025 ondansetron hydrochloride dihydrate Injection, solution 5 mg Current Unavailable Manufacturing 20/10/2025 midazolam Injection, solution 50 mg Current Limited Availability Manufacturing 20/10/2025 vecuronium bromide Injection, powder for 10 mg Resolved Available Manufacturing 20/10/2025 salmeterol xinafoate~fluticasone propionate Inhalation, powder for 72.5 microgram/actuation~250 microgram/actuation Resolved Available Unexpected increase in consumer demand 20/10/2025 desvenlafaxine Tablet, modified release 100 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 20/10/2025 desvenlafaxine Tablet, modified release 50 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 20/10/2025 methylphenidate hydrochloride Capsule, modified release 60 mg Current Limited Availability Manufacturing 20/10/2025 ezetimibe~simvastatin Tablet 10 mg~40 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 20/10/2025 amiodarone hydrochloride Tablet, uncoated 100 mg Current Unavailable Manufacturing 20/10/2025 sugammadex sodium Injection, solution 217.6 mg Current Unavailable Manufacturing 20/10/2025 risperidone Oral Liquid, solution 1 mg/mL Current Limited Availability Manufacturing 20/10/2025 rifampicin Capsule, hard 150 mg Current Limited Availability Manufacturing 20/10/2025 Peginterferon alfa2a Injection, solution 135 microgram Current Unavailable Unexpected increase in consumer demand 20/10/2025 Peginterferon alfa2a Injection, solution 180 microgram Current Unavailable Unexpected increase in consumer demand 20/10/2025 - 2025.10.20
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated desvenlafaxine Tablet, modified release 100 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 20/10/2025 desvenlafaxine Tablet, modified release 50 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 20/10/2025 ezetimibe~simvastatin Tablet 10 mg~40 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 20/10/2025 risperidone Oral Liquid, solution 1 mg/mL Current Limited Availability Manufacturing 20/10/2025 rivaroxaban Tablet, film coated 10 mg Anticipated Available Manufacturing 20/10/2025 rifampicin Capsule, hard 150 mg Current Limited Availability Manufacturing 20/10/2025 phenytoin sodium Injection, solution 100 mg Current Unavailable Manufacturing 17/10/2025 ciprofloxacin hydrochloride Tablet, film coated 555 mg Anticipated Available Manufacturing 17/10/2025 sildenafil citrate Tablet, uncoated 35.1 mg Current Limited Availability Manufacturing 17/10/2025 glipizide Tablet, uncoated 5 mg Anticipated Available Manufacturing 17/10/2025 mesalazine Tablet, modified release 1 g Current Limited Availability Transport / Logistic issues / Storage capacity issues 17/10/2025 atorvastatin calcium trihydrate Tablet, film coated 21.69 mg Current Unavailable Manufacturing 17/10/2025 atorvastatin calcium trihydrate Tablet, film coated 43.38 mg Current Limited Availability Manufacturing 17/10/2025 montelukast sodium Tablet, chewable 5.2 mg Anticipated Available Manufacturing 17/10/2025 carbidopa monohydrate~levodopa~entacapone Tablet, film coated 54 mg~200 mg~200 mg Current Unavailable Manufacturing 17/10/2025 entacapone~carbidopa monohydrate~levodopa Tablet, film coated 200 mg~20.25 mg~75 mg Current Unavailable Manufacturing 17/10/2025 entacapone~levodopa~carbidopa monohydrate Tablet, film coated 200 mg~50 mg~13.5 mg Current Limited Availability Manufacturing 17/10/2025 levodopa~entacapone~carbidopa monohydrate Tablet, film coated 100 mg~200 mg~27 mg Current Unavailable Manufacturing 17/10/2025 entacapone~levodopa~carbidopa monohydrate Tablet, film coated 200 mg~125 mg~33.75 mg Current Unavailable Manufacturing 17/10/2025 carbidopa monohydrate~levodopa~entacapone Tablet, film coated 40.5 mg~150 mg~200 mg Current Unavailable Manufacturing 17/10/2025 pregabalin Capsule, hard 150 mg Current Limited Availability Unexpected increase in consumer demand 17/10/2025 risperidone Tablet, film coated 2 mg Anticipated Available Manufacturing 17/10/2025 gabapentin Tablet, film coated 600 mg Anticipated Available Manufacturing 17/10/2025 metaraminol tartrate Injection, solution 19 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 17/10/2025 amlodipine besilate~olmesartan medoxomil~hydrochlorothiazide Tablet, film coated 13.9 mg~40 mg~12.5 mg Anticipated Available Manufacturing 17/10/2025 naltrexone hydrochloride Tablet, film coated 50 mg Anticipated Available Manufacturing 17/10/2025 tranexamic acid Tablet, film coated 500 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 17/10/2025 prazosin hydrochloride Tablet, uncoated 1.095 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 16/10/2025 tobramycin Injection, solution 80 mg Anticipated Available Manufacturing 16/10/2025 tetracosactide Injection, modified release 1 mg/mL Current Unavailable Manufacturing 16/10/2025 dienogest~ethinylestradiol Tablet, sugar coated 2 mg~.03 mg Anticipated Available Manufacturing 16/10/2025 codeine phosphate hemihydrate Oral Liquid, solution 5 mg/mL Current Unavailable Manufacturing 16/10/2025 ciprofloxacin hydrochloride Tablet, film coated 277.5 mg Current Unavailable Manufacturing 16/10/2025 ciprofloxacin hydrochloride Tablet, film coated 832.5 mg Anticipated Available Manufacturing 16/10/2025 midazolam Injection, solution 5 mg/mL Anticipated Available Manufacturing 16/10/2025 olsalazine sodium Capsule 250 mg Current Unavailable Manufacturing 16/10/2025 finasteride Tablet, film coated 1 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 16/10/2025 lumefantrine~artemether Tablet, dispersible 120 mg~20 mg Discontinued Unavailable Commercial Changes / Commercial viability 16/10/2025 bisoprolol fumarate Tablet 5 mg Anticipated Available Manufacturing 16/10/2025 levetiracetam Tablet, film coated 500 mg Current Limited Availability Manufacturing 16/10/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Manufacturing 16/10/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Manufacturing 16/10/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Anticipated Available Manufacturing 16/10/2025 montelukast sodium Tablet, chewable 4.16 mg Current Unavailable Manufacturing 16/10/2025 montelukast sodium Tablet, chewable 4.16 mg Current Unavailable Manufacturing 16/10/2025 sildenafil citrate Tablet, film coated 28.1 mg Current Unavailable Manufacturing 16/10/2025 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~41.583 mg Resolved Available Manufacturing 16/10/2025 oxytocin Injection, solution 5 IU/mL Resolved Available Unexpected increase in consumer demand 16/10/2025 oxytocin Injection, solution 10 IU/mL Resolved Available Manufacturing 16/10/2025 atorvastatin calcium trihydrate~ezetimibe Tablet, multilayer 10.9 mg~10 mg Resolved Available Manufacturing 16/10/2025 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in consumer demand 16/10/2025 nicorandil Tablet, uncoated 10 mg Current Limited Availability Manufacturing 16/10/2025 tadalafil Tablet, film coated 5 mg Current Limited Availability Manufacturing 16/10/2025 latanoprost Eye Drops, solution .05 mg/mL Anticipated Available Manufacturing 16/10/2025 escitalopram oxalate Tablet, film coated 25.47 mg Current Limited Availability Manufacturing 16/10/2025 eplerenone Tablet, film coated 25 mg Resolved Available Manufacturing 16/10/2025 lacosamide Tablet, film coated 50 mg Anticipated Available Manufacturing 16/10/2025 ambrisentan Tablet, film coated 5 mg Anticipated Available Manufacturing 16/10/2025 nitrofurantoin Capsule, hard 100 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 16/10/2025 methylphenidate hydrochloride Tablet, modified release 54 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 16/10/2025 methylphenidate hydrochloride Tablet, modified release 27 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 16/10/2025 olsalazine sodium Tablet, uncoated 500 mg Current Unavailable Manufacturing 16/10/2025 estradiol hemihydrate Drug delivery system, transdermal 3.09 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 16/10/2025 hydrochlorothiazide~enalapril maleate Tablet, uncoated 6 mg~20 mg Anticipated Available Manufacturing 16/10/2025 valaciclovir hydrochloride Tablet, film coated 1112 mg Current Limited Availability Manufacturing 16/10/2025 estradiol hemihydrate Drug delivery system, transdermal 2.32 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 16/10/2025 galantamine~galantamine hydrobromide Capsule, modified release 16 mg~20.51 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 16/10/2025 diclofenac sodium Tablet, enteric coated 50 mg Discontinued Unavailable Commercial Changes / Commercial viability 15/10/2025 propranolol hydrochloride Tablet, film coated 10 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 15/10/2025 propranolol hydrochloride Tablet, film coated 40 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 15/10/2025 alfentanil hydrochloride Injection, solution 1.0876 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 15/10/2025 pregabalin Capsule, hard 150 mg Resolved Available Manufacturing 15/10/2025 pregabalin Capsule, hard 75 mg Resolved Available Manufacturing 15/10/2025 dabigatran etexilate mesilate Capsule, hard 126.83 mg Resolved Available Manufacturing 15/10/2025 lurasidone hydrochloride Tablet, film coated 80 mg Current Unavailable Manufacturing 15/10/2025 rivaroxaban Tablet, film coated 15 mg Anticipated Available Manufacturing 15/10/2025 levothyroxine sodium Tablet 50 microgram Current Unavailable Unexpected increase in consumer demand 15/10/2025 metronidazole Tablet, film coated 400 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 15/10/2025 rifampicin Capsule, hard 300 mg Current Unavailable Manufacturing 15/10/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 15/10/2025 diclofenac sodium Tablet, enteric coated 25 mg Discontinued Unavailable Commercial Changes / Commercial viability 14/10/2025 valaciclovir hydrochloride Tablet, film coated 556.275 mg Resolved Available Manufacturing 14/10/2025 methylphenidate hydrochloride Capsule, modified release 10 mg Current Limited Availability Manufacturing 14/10/2025 ephedrine sulfate Injection, solution 30 mg/mL Anticipated Available Manufacturing 14/10/2025 montelukast sodium Tablet, chewable 5.2 mg Resolved Available Manufacturing 14/10/2025 primaquine phosphate Tablet, uncoated 13.2 mg Anticipated Available Manufacturing 14/10/2025 methylphenidate hydrochloride Capsule, modified release 60 mg Current Unavailable Manufacturing 14/10/2025 olmesartan medoxomil~hydrochlorothiazide Tablet 20 mg~12.5 mg Anticipated Available Manufacturing 14/10/2025 atenolol Tablet, film coated 50 mg Current Unavailable Manufacturing 14/10/2025 nebivolol hydrochloride Tablet 1.363 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 14/10/2025 metoprolol succinate Tablet, modified release 23.75 mg Resolved Available Manufacturing 14/10/2025 levothyroxine sodium Tablet 100 microgram Current Unavailable Unexpected increase in consumer demand 14/10/2025 methylphenidate hydrochloride Capsule, modified release 20 mg Current Limited Availability Manufacturing 14/10/2025 methylphenidate hydrochloride Capsule, modified release 30 mg Current Limited Availability Manufacturing 14/10/2025 methylphenidate hydrochloride Capsule, modified release 40 mg Current Unavailable Manufacturing 14/10/2025 phenytoin sodium Injection, solution 250 mg Anticipated Available Manufacturing 13/10/2025 lidocaine hydrochloride Injection, solution 20 mg/mL Resolved Available Manufacturing 13/10/2025 adrenaline (epinephrine) acid tartrate~lidocaine hydrochloride Injection, solution 9.1 microgram/mL~20 mg/mL Resolved Available Manufacturing 13/10/2025 venlafaxine hydrochloride Capsule, modified release 84.86 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 13/10/2025 ethinylestradiol~drospirenone Tablet 30 microgram~3 mg Current Limited Availability Manufacturing 13/10/2025 galantamine hydrobromide Capsule, modified release 10.252 mg Current Unavailable Manufacturing 13/10/2025 milrinone Injection, concentrated 10 mg Current Limited Availability Manufacturing 13/10/2025 irbesartan Tablet, film coated 150 mg Current Unavailable Manufacturing 13/10/2025 montelukast sodium Tablet, chewable 5.2 mg Current Unavailable Manufacturing 13/10/2025 potassium chloride Tablet, modified release 600 mg Resolved Available Manufacturing 13/10/2025 lacosamide Tablet, film coated 100 mg Resolved Available Manufacturing 13/10/2025 phenytoin sodium Injection, solution 100 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 13/10/2025 bromazepam Tablet, uncoated 6 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 13/10/2025 cisatracurium besilate Injection, solution 2.68 mg/mL Resolved Available Manufacturing 13/10/2025 pramipexole dihydrochloride monohydrate Tablet, uncoated .25 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 13/10/2025 spironolactone Tablet, film coated 25 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 13/10/2025 - 2025.10.13
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated tramadol hydrochloride Capsule 50 mg Resolved Available Manufacturing 10/10/2025 topiramate Tablet, film coated 50 mg Anticipated Available Manufacturing 10/10/2025 ciprofloxacin hydrochloride Tablet, film coated 832.5 mg Anticipated Available Manufacturing 10/10/2025 tetrabenazine Tablet, uncoated 25 mg Resolved Available Manufacturing 10/10/2025 venlafaxine hydrochloride Capsule, modified release 169.71 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 10/10/2025 fosaprepitant dimeglumine Injection, powder for 257.6 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 10/10/2025 temozolomide Capsule, hard 5 mg Current Limited Availability Manufacturing 10/10/2025 galantamine hydrobromide Capsule, modified release 20.504 mg Current Unavailable Manufacturing 10/10/2025 galantamine hydrobromide Capsule, modified release 30.756 mg Current Unavailable Manufacturing 10/10/2025 montelukast sodium Tablet, chewable 4.16 mg Current Unavailable Manufacturing 10/10/2025 raloxifene hydrochloride Tablet, film coated 60 mg Current Unavailable Manufacturing 10/10/2025 quetiapine fumarate Tablet, film coated 115.12 mg Anticipated Available Commercial Changes / Commercial viability 10/10/2025 quetiapine fumarate Tablet, film coated 345.36 mg Anticipated Available Commercial Changes / Commercial viability 10/10/2025 cisatracurium besilate Injection, solution 7.04 mg Current Limited Availability Manufacturing 10/10/2025 mebeverine hydrochloride Tablet, film coated 135 mg Current Unavailable Manufacturing 10/10/2025 ropinirole hydrochloride Tablet, film coated .285 mg Current Unavailable Manufacturing 10/10/2025 lacosamide Tablet, film coated 150 mg Current Limited Availability Manufacturing 10/10/2025 Trastuzumab Injection, powder for 156 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 10/10/2025 teriflunomide Tablet, film coated 14 mg Current Limited Availability Manufacturing 10/10/2025 rivaroxaban Tablet, film coated 10 mg Anticipated Available Manufacturing 10/10/2025 valaciclovir hydrochloride Tablet, film coated 1112 mg Current Limited Availability Manufacturing 10/10/2025 phenoxymethylpenicillin potassium Oral Liquid, powder for 28.284 mg/mL Current Unavailable Manufacturing 9/10/2025 lansoprazole Tablet, orally disintegrating 30 mg Current Limited Availability Manufacturing 9/10/2025 chloramphenicol Eye Drops 5 mg/mL Resolved Available Manufacturing 9/10/2025 lansoprazole Tablet, orally disintegrating 15 mg Current Unavailable Manufacturing 9/10/2025 desvenlafaxine Tablet, modified release 100 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 9/10/2025 desvenlafaxine Tablet, modified release 50 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 9/10/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Unexpected increase in consumer demand 9/10/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Unexpected increase in consumer demand 9/10/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Anticipated Available Manufacturing 9/10/2025 hydrocortisone Tablet, uncoated 4 mg Anticipated Available Manufacturing 9/10/2025 ezetimibe~simvastatin Tablet 10 mg~40 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 9/10/2025 fingolimod hydrochloride Capsule 560 microgram Anticipated Available Manufacturing 9/10/2025 estradiol Drug delivery system, transdermal .39 mg Current Unavailable Manufacturing 9/10/2025 estradiol Drug delivery system, transdermal .78 mg Current Unavailable Manufacturing 9/10/2025 estradiol Drug delivery system, transdermal 1.17 mg Current Unavailable Manufacturing 9/10/2025 estradiol Drug delivery system, transdermal 1.56 mg Current Unavailable Manufacturing 9/10/2025 lenalidomide Capsule 5 mg Current Limited Availability Manufacturing 9/10/2025 bleomycin sulfate Injection, powder for 15000 IU Anticipated Available Manufacturing 9/10/2025 doxorubicin hydrochloride Injection, concentrated 20 mg Resolved Available Manufacturing 9/10/2025 methylphenidate hydrochloride Tablet, modified release 18 mg Current Limited Availability Manufacturing 9/10/2025 methylphenidate hydrochloride Tablet, modified release 36 mg Current Limited Availability Manufacturing 9/10/2025 tranexamic acid Tablet, film coated 500 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 8/10/2025 galantamine hydrobromide Capsule, modified release 30.768 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 8/10/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 8/10/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Manufacturing 8/10/2025 valsartan~hydrochlorothiazide Tablet, film coated 320 mg~25 mg Resolved Available Manufacturing 8/10/2025 temozolomide Capsule, hard 20 mg Anticipated Available Manufacturing 8/10/2025 escitalopram oxalate Tablet, film coated 25.548 mg Anticipated Available Manufacturing 8/10/2025 lansoprazole Tablet, orally disintegrating 30 mg Current Unavailable Manufacturing 8/10/2025 anastrozole Tablet, film coated 1 mg Current Limited Availability Manufacturing 8/10/2025 clonidine hydrochloride Tablet 100 microgram Resolved Available Manufacturing 8/10/2025 hydrochlorothiazide~irbesartan Tablet, film coated 12.5 mg~150 mg Current Unavailable Manufacturing 8/10/2025 hydrochlorothiazide~irbesartan Tablet, film coated 25 mg~300 mg Current Unavailable Manufacturing 8/10/2025 metformin hydrochloride Tablet, film coated 1000 mg Current Unavailable Unexpected increase in consumer demand 8/10/2025 Mecasermin Injection, solution 10 mg/mL Resolved Available Unexpected increase in consumer demand 8/10/2025 erlotinib hydrochloride Tablet, film coated 27.32 mg Current Unavailable Unexpected increase in consumer demand 8/10/2025 spironolactone Tablet, uncoated 25 mg Resolved Available Manufacturing 8/10/2025 bortezomib Injection, solution 3.5 mg Resolved Available Manufacturing 8/10/2025 paracetamol Tablet, modified release 665 mg Resolved Available Transport / Logistic issues / Storage capacity issues 8/10/2025 naproxen Tablet, uncoated 250 mg Resolved Available Manufacturing 8/10/2025 tranexamic acid Tablet, film coated 500 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 8/10/2025 trandolapril Capsule, hard 2 mg Resolved Available Manufacturing 8/10/2025 rifampicin Capsule, hard 300 mg Current Unavailable Manufacturing 8/10/2025 clindamycin phosphate Cream 22.8 mg/g Resolved Available Transport / Logistic issues / Storage capacity issues 8/10/2025 paclitaxel Injection, concentrated 6 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 8/10/2025 labetalol hydrochloride Tablet, film coated 100 mg Current Limited Availability Manufacturing 8/10/2025 dosulepin hydrochloride Tablet, film coated 75 mg Current Limited Availability Manufacturing 8/10/2025 metformin hydrochloride Tablet, film coated 1000 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 8/10/2025 acetylcysteine Injection, concentrated 2 g Current Limited Availability Manufacturing 7/10/2025 topiramate Tablet, film coated 25 mg Current Unavailable Manufacturing 7/10/2025 ciprofloxacin hydrochloride Tablet, film coated 277.5 mg Current Unavailable Manufacturing 7/10/2025 acetazolamide sodium Injection, powder for 549.5 mg Current Unavailable Manufacturing 7/10/2025 lamotrigine Tablet, chewable 50 mg Anticipated Available Manufacturing 7/10/2025 lamotrigine Tablet, chewable 100 mg Current Unavailable Manufacturing 7/10/2025 olanzapine Tablet, film coated 5 mg Current Unavailable Manufacturing 7/10/2025 methylphenidate hydrochloride Capsule, modified release 10 mg Current Limited Availability Manufacturing 7/10/2025 levetiracetam Tablet, film coated 500 mg Current Limited Availability Manufacturing 7/10/2025 sildenafil citrate Tablet, film coated 140.45 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 7/10/2025 sulfamethoxazole~trimethoprim Tablet, uncoated 800 mg~160 mg Resolved Available Manufacturing 7/10/2025 exemestane Tablet, sugar coated 25 mg Anticipated Available Manufacturing 7/10/2025 olanzapine Tablet, orally disintegrating 10 mg Anticipated Available Manufacturing 7/10/2025 olanzapine Tablet, orally disintegrating 5 mg Anticipated Available Manufacturing 7/10/2025 atorvastatin calcium trihydrate Tablet, film coated 21.69 mg Current Unavailable Manufacturing 7/10/2025 atorvastatin calcium trihydrate Tablet, film coated 43.38 mg Anticipated Available Manufacturing 7/10/2025 galantamine hydrobromide Capsule, modified release 10.252 mg Current Unavailable Manufacturing 7/10/2025 galantamine hydrobromide Capsule, modified release 30.756 mg Current Unavailable Manufacturing 7/10/2025 galantamine hydrobromide Capsule, modified release 20.504 mg Current Unavailable Manufacturing 7/10/2025 indapamide hemihydrate Tablet, sugar coated 2.5 mg Current Limited Availability Manufacturing 7/10/2025 montelukast sodium Tablet, chewable 4.16 mg Current Unavailable Manufacturing 7/10/2025 isotretinoin Capsule, soft 10 mg Current Unavailable Manufacturing 7/10/2025 isotretinoin Capsule, soft 20 mg Current Unavailable Manufacturing 7/10/2025 enalapril maleate Tablet 5 mg Anticipated Available Manufacturing 7/10/2025 phenobarbital Tablet, uncoated 30 mg Anticipated Available Manufacturing 7/10/2025 metformin hydrochloride Tablet, film coated 1000 mg Current Unavailable Manufacturing 7/10/2025 citalopram hydrobromide Tablet, film coated 49.98 mg Resolved Available Manufacturing 7/10/2025 ezetimibe Tablet, uncoated 10 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 7/10/2025 tranexamic acid Tablet, film coated 500 mg Current Limited Availability Manufacturing 7/10/2025 ivabradine hydrochloride Tablet, film coated 8.085 mg Resolved Available Manufacturing 7/10/2025 teriflunomide Tablet, film coated 14 mg Current Unavailable Manufacturing 7/10/2025 pregabalin Capsule, hard 300 mg Anticipated Available Manufacturing 7/10/2025 oseltamivir phosphate Capsule, hard 98.524 mg Current Limited Availability Manufacturing 7/10/2025 sitagliptin hydrochloride monohydrate~metformin hydrochloride Tablet, modified release 56.685 mg~1000 mg Anticipated Available Manufacturing 7/10/2025 Teriparatide Injection, solution .25 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 7/10/2025 Teriparatide Injection, solution 250 microgram/mL Current Unavailable Manufacturing 7/10/2025 minocycline hydrochloride dihydrate Tablet, film coated 54 mg Resolved Available Manufacturing 7/10/2025 olanzapine Injection, powder for 10 mg Resolved Available Unexpected increase in consumer demand 7/10/2025 ciprofloxacin hydrochloride Tablet, film coated 873.32 mg Current Limited Availability Manufacturing 7/10/2025 methylphenidate hydrochloride Capsule, modified release 30 mg Current Limited Availability Manufacturing 7/10/2025 amoxicillin trihydrate Oral Liquid, powder for 28.7 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 6/10/2025 - 2025.10.05
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated trandolapril~verapamil hydrochloride Tablet, film coated 4 mg~240 mg Current Limited Availability Manufacturing 3/10/2025 acetylcholine chloride Solution, powder for irrigation 10 mg/mL Resolved Available Manufacturing 3/10/2025 ramipril Tablet, uncoated 1.25 mg Anticipated Available Manufacturing 3/10/2025 Equine antithymocyte immunoglobulin Injection, solution 50 mg/mL Resolved Available Manufacturing 3/10/2025 bromocriptine mesilate Tablet, uncoated 2.87 mg Resolved Available Manufacturing 3/10/2025 buprenorphine hydrochloride Injection, solution 324 microgram/mL Current Unavailable Manufacturing 3/10/2025 iopromide Injection, solution 498.72 mg/mL Current Unavailable Manufacturing 3/10/2025 silver sulfadiazine Cream 10 mg/g Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 3/10/2025 silver sulfadiazine Cream 10 mg/g Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 3/10/2025 risperidone Tablet, film coated 2 mg Anticipated Available Manufacturing 3/10/2025 pioglitazone hydrochloride Tablet 49.9 mg Anticipated Available Manufacturing 3/10/2025 hydrocortisone sodium succinate Injection, powder for 134 mg Anticipated Available Manufacturing 3/10/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Manufacturing 3/10/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Manufacturing 3/10/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Anticipated Available Manufacturing 3/10/2025 trandolapril Capsule, hard .5 mg Discontinued Unavailable Commercial Changes / Commercial viability 3/10/2025 trandolapril Capsule, hard 1 mg Discontinued Unavailable Commercial Changes / Commercial viability 3/10/2025 trandolapril Capsule, hard 2 mg Discontinued Unavailable Commercial Changes / Commercial viability 3/10/2025 trandolapril Capsule, hard 4 mg Discontinued Unavailable Commercial Changes / Commercial viability 3/10/2025 metoprolol succinate Tablet, modified release 95 mg Discontinued Unavailable Commercial Changes / Commercial viability 3/10/2025 metoprolol succinate Tablet, modified release 47.5 mg Discontinued Unavailable Commercial Changes / Commercial viability 3/10/2025 metoprolol succinate Tablet, modified release 190 mg Discontinued Unavailable Commercial Changes / Commercial viability 3/10/2025 metoprolol succinate Tablet, modified release 23.75 mg Discontinued Unavailable Commercial Changes / Commercial viability 3/10/2025 paclitaxel Injection, concentrated 300 mg Current Unavailable Manufacturing 3/10/2025 adrenaline (epinephrine) acid tartrate~articaine hydrochloride Injection, solution 18.2 microgram/mL~40 mg/mL Resolved Available Transport / Logistic issues / Storage capacity issues 3/10/2025 citalopram hydrobromide Tablet, film coated 12.495 mg Current Limited Availability Manufacturing 3/10/2025 bimatoprost Eye Drops .3 mg/mL Current Unavailable Manufacturing 3/10/2025 methylphenidate hydrochloride Capsule, modified release 60 mg Current Unavailable Manufacturing 3/10/2025 hydrochlorothiazide~irbesartan Tablet, film coated 12.5 mg~300 mg Current Unavailable Manufacturing 3/10/2025 nizatidine Capsule, hard 150 mg Current Unavailable Manufacturing 3/10/2025 ambrisentan Tablet, film coated 10 mg Anticipated Available Manufacturing 3/10/2025 mefenamic acid Capsule, hard 250 mg Current Unavailable Manufacturing 3/10/2025 dabigatran etexilate mesilate Capsule, hard 126.83 mg Current Limited Availability Manufacturing 3/10/2025 posaconazole Tablet, modified release 100 mg Resolved Available Manufacturing 3/10/2025 sacubitril~valsartan Tablet, film coated 48.6 mg~51.4 mg Resolved Available Manufacturing 3/10/2025 valsartan~sacubitril Tablet, film coated 102.8 mg~97.2 mg Resolved Available Manufacturing 3/10/2025 carboplatin Injection, solution 10 mg/mL Resolved Available Unexpected increase in demand due to other sponsors unable to supply 3/10/2025 iotroxate meglumine Injection, solution 105.46 mg/mL Current Unavailable Transport / Logistic issues / Storage capacity issues 3/10/2025 methylphenidate hydrochloride Capsule, modified release 20 mg Current Limited Availability Manufacturing 3/10/2025 methylphenidate hydrochloride Capsule, modified release 40 mg Current Unavailable Manufacturing 3/10/2025 Measles virus~Rubella virus~Mumps virus Injection, powder for 1000 CCID50~1000 CCID50~5000 CCID50 Resolved Available Unexpected increase in consumer demand 3/10/2025 prazosin hydrochloride Tablet, uncoated 1.095 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 2/10/2025 prazosin hydrochloride Tablet, uncoated 5.476 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 2/10/2025 metformin hydrochloride Tablet, film coated 500 mg Current Unavailable Manufacturing 2/10/2025 valsartan~hydrochlorothiazide Tablet, film coated 320 mg~25 mg Current Limited Availability Manufacturing 2/10/2025 risperidone Tablet, film coated .5 mg Current Unavailable Manufacturing 2/10/2025 entecavir Tablet, film coated .5 mg Current Unavailable Manufacturing 2/10/2025 entecavir Tablet, film coated 1 mg Anticipated Available Manufacturing 2/10/2025 Trastuzumab Injection, solution 600 mg Resolved Available Manufacturing 2/10/2025 rosuvastatin calcium Tablet, film coated 20.84 mg Current Limited Availability Unexpected increase in consumer demand 2/10/2025 azacitidine Injection, powder for 100 mg Resolved Available Manufacturing 2/10/2025 tranexamic acid Tablet, film coated 500 mg Current Unavailable Manufacturing 2/10/2025 ambrisentan Tablet, film coated 5 mg Anticipated Available Manufacturing 2/10/2025 deferasirox Tablet, film coated 90 mg Current Limited Availability Manufacturing 2/10/2025 deferasirox Tablet, film coated 360 mg Current Limited Availability Manufacturing 2/10/2025 metoprolol succinate Tablet, modified release 23.75 mg Current Limited Availability Manufacturing 2/10/2025 sitagliptin hydrochloride monohydrate~metformin hydrochloride Tablet, film coated 56.69 mg~1000 mg Resolved Available Manufacturing 2/10/2025 quinagolide hydrochloride Tablet, uncoated .0819 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 2/10/2025 prazosin hydrochloride Tablet, uncoated 1.1 mg Current Unavailable Manufacturing 2/10/2025 sertraline hydrochloride Tablet, film coated 56 mg Current Unavailable Manufacturing 2/10/2025 sertraline hydrochloride Tablet, film coated 112 mg Current Limited Availability Manufacturing 2/10/2025 mirtazapine Tablet, film coated 30 mg Resolved Available Manufacturing 2/10/2025 live varicella vaccine Injection, powder for 2700 PFU/mL Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 1/10/2025 sertraline hydrochloride Tablet, film coated 55.96 mg Current Unavailable Manufacturing 1/10/2025 risperidone Tablet 1 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 1/10/2025 atorvastatin calcium trihydrate Tablet, film coated 86.76 mg Current Limited Availability Manufacturing 1/10/2025 atorvastatin calcium trihydrate Tablet, film coated 21.69 mg Current Limited Availability Manufacturing 1/10/2025 atorvastatin calcium trihydrate Tablet, film coated 43.38 mg Current Unavailable Manufacturing 1/10/2025 ceftaroline fosamil Injection, powder for 600 mg Resolved Available Manufacturing 1/10/2025 clopidogrel hydrogen sulfate~aspirin Tablet 97.87 mg~100 mg Resolved Available Manufacturing 1/10/2025 live varicella vaccine Injection, powder for 4000 PFU/mL Current Only available under NIP or government programs Unexpected increase in consumer demand 1/10/2025 mesalazine Tablet, enteric coated 800 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 1/10/2025 Rabies virus Injection, powder for 2.5 IU Current Emergency Supply Only Unexpected increase in consumer demand 1/10/2025 teriflunomide Tablet, film coated 14 mg Current Limited Availability Manufacturing 1/10/2025 Mecasermin Injection, solution 10 mg/mL Current Limited Availability Unexpected increase in consumer demand 1/10/2025 estradiol~estradiol~norethisterone acetate Drug delivery system, transdermal .78 mg~.62 mg~2.7 mg Resolved Available Manufacturing 1/10/2025 GluureaLys(ahx)hbedCC Injection, powder for 25 microgram Current Unavailable Manufacturing 1/10/2025 tranexamic acid Tablet, film coated 500 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 1/10/2025 rifampicin Capsule, hard 150 mg Current Limited Availability Manufacturing 1/10/2025 lidocaine hydrochloride monohydrate Injection, solution 20 mg/mL Resolved Available Manufacturing 1/10/2025 prazosin hydrochloride Tablet, uncoated 2.2 mg Current Unavailable Manufacturing 1/10/2025 prazosin hydrochloride Tablet, uncoated 5.5 mg Current Unavailable Manufacturing 1/10/2025 primidone Tablet, uncoated 250 mg Current Limited Availability Manufacturing 30/09/2025 lidocaine hydrochloride Gel 20 mg/g Current Limited Availability Manufacturing 30/09/2025 pantoprazole sodium sesquihydrate Tablet, enteric coated 45.4 mg Current Limited Availability Unexpected increase in consumer demand 30/09/2025 midazolam Injection, solution 50 mg Resolved Available Manufacturing 30/09/2025 midazolam Injection, solution 50 mg Current Limited Availability Manufacturing 30/09/2025 docetaxel Injection, concentrated 80 mg Resolved Available Manufacturing 30/09/2025 rosuvastatin calcium Tablet, film coated 41.68 mg Current Limited Availability Manufacturing 30/09/2025 rosuvastatin calcium Tablet, film coated 10.42 mg Current Unavailable Manufacturing 30/09/2025 pregabalin Capsule, hard 75 mg Current Limited Availability Manufacturing 30/09/2025 atorvastatin calcium trihydrate Tablet, film coated 86.76 mg Current Unavailable Manufacturing 30/09/2025 dabigatran etexilate mesilate Capsule, hard 172.95 mg Current Unavailable Manufacturing 30/09/2025 oseltamivir phosphate Capsule, hard 98.524 mg Current Limited Availability Manufacturing 30/09/2025 cabazitaxel Injection, concentrated 60 mg Current Limited Availability Manufacturing 30/09/2025 fentanyl citrate Injection, solution 785 microgram Current Unavailable Manufacturing 30/09/2025 ropivacaine hydrochloride Injection, solution 10 mg/mL Current Unavailable Manufacturing 30/09/2025 gefitinib Tablet, film coated 250 mg Discontinued Unavailable Commercial Changes / Commercial viability 30/09/2025 betamethasone valerate Cream 1.21 mg/g Resolved Available Manufacturing 29/09/2025 fludarabine phosphate Injection, powder for 50 mg Current Limited Availability Manufacturing 29/09/2025 finasteride Tablet, film coated 1 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 29/09/2025 sulfamethoxazole~trimethoprim Tablet, uncoated 800 mg~160 mg Current Limited Availability Manufacturing 29/09/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Current Limited Availability Unexpected increase in consumer demand 29/09/2025 chloramphenicol Eye Drops 5 mg/mL Current Unavailable Manufacturing 29/09/2025 phenobarbital Tablet, uncoated 30 mg Anticipated Available Manufacturing 29/09/2025 quetiapine fumarate Tablet, modified release 57.5 mg Anticipated Available Unexpected increase in consumer demand 29/09/2025 irbesartan Tablet, film coated 75 mg Current Limited Availability Manufacturing 29/09/2025 ivabradine hydrochloride Tablet, film coated 5.39 mg Resolved Available Manufacturing 29/09/2025 dimethyl fumarate Capsule, enteric 120 mg Resolved Available Manufacturing 29/09/2025 lurasidone hydrochloride Tablet, film coated 40 mg Current Unavailable Manufacturing 29/09/2025 lurasidone hydrochloride Tablet, film coated 80 mg Current Unavailable Manufacturing 29/09/2025 potassium chloride Tablet, modified release 600 mg Current Limited Availability Manufacturing 29/09/2025 spironolactone Tablet, uncoated 25 mg Current Limited Availability Manufacturing 29/09/2025 tetrabenazine Tablet, uncoated 25 mg Current Unavailable Manufacturing 29/09/2025 lidocaine hydrochloride Injection, solution 10 mg/mL Current Unavailable Manufacturing 29/09/2025 cisatracurium besilate Injection, solution 2.68 mg/mL Current Unavailable Manufacturing 29/09/2025 olanzapine Tablet, film coated 5 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 29/09/2025 olanzapine Wafer 5 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 29/09/2025 - 2025.09.28
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated fentanyl Drug delivery system, transdermal 4.2 mg Discontinued Unavailable Manufacturing 26/09/2025 fentanyl Drug delivery system, transdermal 8.4 mg Discontinued Unavailable Manufacturing 26/09/2025 fentanyl Drug delivery system, transdermal 12.6 mg Discontinued Unavailable Manufacturing 26/09/2025 fentanyl Drug delivery system, transdermal 16.8 mg Discontinued Unavailable Manufacturing 26/09/2025 fentanyl Drug delivery system, transdermal 2.1 mg Discontinued Unavailable Manufacturing 26/09/2025 stannous chloride~etifenin Injection, powder for .42 mg~20 mg Current Unavailable Manufacturing 26/09/2025 nortriptyline Tablet, film coated 10 mg Resolved Available Manufacturing 26/09/2025 ceftazidime pentahydrate Injection, powder for 2.328 g Current Limited Availability Manufacturing 26/09/2025 finasteride Tablet, film coated 1 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 26/09/2025 olanzapine Tablet, orally disintegrating 5 mg Anticipated Available Manufacturing 26/09/2025 fentanyl Drug delivery system, transdermal 5.1 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 26/09/2025 fentanyl Drug delivery system, transdermal 2.55 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 26/09/2025 vecuronium bromide Injection, powder for 10 mg Current Limited Availability Manufacturing 26/09/2025 pioglitazone hydrochloride Tablet 49.9 mg Anticipated Available Manufacturing 26/09/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Manufacturing 26/09/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Manufacturing 26/09/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Anticipated Available Manufacturing 26/09/2025 ondansetron hydrochloride dihydrate Tablet, film coated 4.986 mg Anticipated Available Manufacturing 26/09/2025 galantamine hydrobromide Capsule, modified release 10.252 mg Current Unavailable Manufacturing 26/09/2025 galantamine hydrobromide Capsule, modified release 30.756 mg Current Unavailable Manufacturing 26/09/2025 galantamine hydrobromide Capsule, modified release 20.504 mg Current Unavailable Manufacturing 26/09/2025 sildenafil citrate Tablet, film coated 28.1 mg Current Unavailable Manufacturing 26/09/2025 quetiapine fumarate Tablet, modified release 57.565 mg Anticipated Available Manufacturing 26/09/2025 pramipexole dihydrochloride monohydrate Tablet, modified release .375 mg Current Limited Availability Manufacturing 26/09/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Unexpected increase in consumer demand 26/09/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Anticipated Available Manufacturing 26/09/2025 citalopram hydrobromide Tablet, film coated 12.495 mg Current Unavailable Manufacturing 26/09/2025 citalopram hydrobromide Tablet, film coated 49.98 mg Current Unavailable Manufacturing 26/09/2025 fluticasone propionate Inhalation, powder for 20 mg/g Resolved Available Manufacturing 26/09/2025 cidofovir Injection, concentrated 75 mg/mL Resolved Available Manufacturing 26/09/2025 ambrisentan Tablet, film coated 5 mg Anticipated Available Manufacturing 26/09/2025 lorazepam Tablet 1 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 26/09/2025 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~41.6 mg Resolved Available Manufacturing 26/09/2025 stannous chloride dihydrate Injection, powder for 19.2 microgram/mL Current Unavailable Manufacturing 26/09/2025 nizatidine Capsule, hard 300 mg Anticipated Available Manufacturing 26/09/2025 mesalazine Suppository, compressed 1000 mg Resolved Available Transport / Logistic issues / Storage capacity issues 26/09/2025 lidocaine hydrochloride~adrenaline (epinephrine) acid tartrate Injection, solution 20 mg/mL~9.1 microgram/mL Current Limited Availability Manufacturing 25/09/2025 sildenafil citrate Tablet, uncoated 35.1 mg Anticipated Available Manufacturing 25/09/2025 valaciclovir hydrochloride Tablet, film coated 556.275 mg Anticipated Available Manufacturing 25/09/2025 risperidone Tablet, film coated 2 mg Anticipated Available Manufacturing 25/09/2025 bisoprolol fumarate Tablet 2.5 mg Current Limited Availability Manufacturing 25/09/2025 bisoprolol fumarate Tablet 5 mg Anticipated Available Manufacturing 25/09/2025 bisoprolol fumarate Tablet 10 mg Anticipated Available Manufacturing 25/09/2025 sildenafil citrate Tablet, film coated 140.45 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 25/09/2025 ondansetron hydrochloride dihydrate Tablet, film coated 9.972 mg Current Limited Availability Manufacturing 25/09/2025 exemestane Tablet, sugar coated 25 mg Anticipated Available Manufacturing 25/09/2025 montelukast sodium Tablet, chewable 5.2 mg Resolved Available Unexpected increase in consumer demand 25/09/2025 linezolid Tablet, film coated 600 mg Current Unavailable Manufacturing 25/09/2025 carbidopa monohydrate~entacapone~levodopa Tablet, film coated 27 mg~200 mg~100 mg Current Limited Availability Unexpected increase in consumer demand 25/09/2025 carbidopa monohydrate~entacapone~levodopa Tablet, film coated 40.5 mg~200 mg~150 mg Current Limited Availability Unexpected increase in consumer demand 25/09/2025 levodopa~carbidopa monohydrate~entacapone Tablet, film coated 200 mg~54.1 mg~200 mg Current Limited Availability Unexpected increase in consumer demand 25/09/2025 irbesartan Tablet, film coated 150 mg Current Unavailable Manufacturing 25/09/2025 nizatidine Capsule, hard 150 mg Current Unavailable Manufacturing 25/09/2025 nitisinone Tablet 10 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 25/09/2025 nitisinone Tablet 5 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 25/09/2025 lamotrigine Tablet, chewable 50 mg Anticipated Available Manufacturing 25/09/2025 lamotrigine Tablet, chewable 100 mg Current Limited Availability Manufacturing 25/09/2025 naltrexone hydrochloride Tablet, film coated 50 mg Resolved Available Manufacturing 25/09/2025 desvenlafaxine Tablet, modified release 100 mg Resolved Available Manufacturing 25/09/2025 valaciclovir hydrochloride Tablet, film coated 1112 mg Anticipated Available Manufacturing 25/09/2025 methyl aminolevulinate hydrochloride Cream 200 mg/g Resolved Available Manufacturing 25/09/2025 terbinafine hydrochloride Tablet, uncoated 281.25 mg Current Limited Availability Manufacturing 24/09/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.9 mg Current Limited Availability Unexpected increase in consumer demand 24/09/2025 indapamide hemihydrate~perindopril erbumine Tablet 1.25 mg~4 mg Current Unavailable Manufacturing 24/09/2025 tobramycin Capsule, hard 28 mg Anticipated Available Manufacturing 24/09/2025 valsartan~hydrochlorothiazide Tablet, film coated 320 mg~25 mg Current Unavailable Manufacturing 24/09/2025 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~41.583 mg Resolved Available Manufacturing 24/09/2025 entecavir Tablet, film coated 1 mg Anticipated Available Manufacturing 24/09/2025 anastrozole Tablet, film coated 1 mg Current Limited Availability Manufacturing 24/09/2025 carbidopa monohydrate~levodopa Tablet, uncoated 27 mg~100 mg Current Limited Availability Manufacturing 24/09/2025 cabazitaxel Injection, concentrated 60 mg Current Limited Availability Manufacturing 24/09/2025 oxaliplatin Injection, concentrated 100 mg Resolved Available Manufacturing 24/09/2025 sugammadex sodium Injection, solution 217.6 mg Current Unavailable Manufacturing 24/09/2025 trandolapril Capsule, hard 2 mg Current Unavailable Manufacturing 24/09/2025 Tiger snake antivenom Injection, concentrated 3000 U Resolved Available Manufacturing 24/09/2025 fluvastatin sodium Tablet, modified release 84.24 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 24/09/2025 prazosin hydrochloride Tablet, uncoated 2.19 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 23/09/2025 bromocriptine mesilate Tablet, uncoated 2.87 mg Current Unavailable Manufacturing 23/09/2025 Somatropin Injection, powder for 12 mg/mL Anticipated Available Unexpected increase in consumer demand 23/09/2025 fluticasone propionate~salmeterol xinafoate Inhalation, pressurised 125 microgram/actuation~36.3 microgram/actuation Resolved Available Unexpected increase in consumer demand 23/09/2025 capecitabine Tablet, film coated 500 mg Resolved Available Unexpected increase in consumer demand 23/09/2025 Rabies virus Injection, powder for 2.5 IU Current Limited Availability Unexpected increase in consumer demand 23/09/2025 letrozole Tablet, film coated 2.5 mg Current Limited Availability Manufacturing 23/09/2025 posaconazole Tablet, modified release 100 mg Current Unavailable Manufacturing 23/09/2025 Adalimumab Injection, solution 20 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 23/09/2025 Adalimumab Injection, solution 40 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 23/09/2025 metronidazole Tablet, film coated 400 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 23/09/2025 carbidopa monohydrate~levodopa Tablet, uncoated 26.9 mg~100 mg Current Limited Availability Manufacturing 23/09/2025 spironolactone Tablet, film coated 100 mg Current Limited Availability Manufacturing 23/09/2025 bupivacaine hydrochloride monohydrate Injection, solution 52.7 mg Resolved Available Manufacturing 22/09/2025 sertraline hydrochloride Tablet, film coated 56 mg Discontinued Unavailable Commercial Changes / Commercial viability 22/09/2025 sertraline hydrochloride Tablet, film coated 112 mg Discontinued Unavailable Commercial Changes / Commercial viability 22/09/2025 varenicline tartrate~varenicline tartrate Tablet, film coated 1.71 mg~.85 mg Discontinued Unavailable Manufacturing 22/09/2025 varenicline tartrate Tablet, film coated 1.71 mg Discontinued Unavailable Manufacturing 22/09/2025 fludarabine phosphate Injection, powder for 50 mg Current Limited Availability Manufacturing 22/09/2025 aripiprazole Tablet, uncoated 30 mg Resolved Available Manufacturing 22/09/2025 methylphenidate hydrochloride Capsule, modified release 10 mg Current Limited Availability Manufacturing 22/09/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.9 mg Resolved Available Unexpected increase in consumer demand 22/09/2025 atorvastatin calcium trihydrate Tablet, film coated 86.76 mg Anticipated Available Manufacturing 22/09/2025 ropivacaine hydrochloride Injection, solution 2 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 22/09/2025 ropivacaine hydrochloride Injection, solution 7.5 mg/mL Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 22/09/2025 ropivacaine hydrochloride Injection, solution 100 mg Resolved Available Transport / Logistic issues / Storage capacity issues 22/09/2025 quetiapine fumarate Tablet, modified release 345.39 mg Current Limited Availability Manufacturing 22/09/2025 quetiapine fumarate Tablet, modified release 345.39 mg Anticipated Available Manufacturing 22/09/2025 quetiapine fumarate Tablet, modified release 230.26 mg Anticipated Available Manufacturing 22/09/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Unavailable Unexpected increase in consumer demand 22/09/2025 tranexamic acid Tablet, film coated 500 mg Current Limited Availability Manufacturing 22/09/2025 metformin hydrochloride Tablet, film coated 1000 mg Current Unavailable Unexpected increase in consumer demand 22/09/2025 solifenacin succinate Tablet, film coated 5 mg Current Unavailable Manufacturing 22/09/2025 Mecasermin Injection, solution 10 mg/mL Anticipated Available Unexpected increase in consumer demand 22/09/2025 naloxone hydrochloride dihydrate Injection 440 microgram Resolved Available Unexpected increase in consumer demand 22/09/2025 midazolam maleate Solution 10.2 mg Resolved Available Manufacturing 22/09/2025 nitrofurantoin Capsule, hard 100 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 22/09/2025 palonosetron hydrochloride~fosnetupitant chloride hydrochloride Injection, concentrated 280 microgram~260 mg Anticipated Available Manufacturing 22/09/2025 thiotepa Injection, powder for 15 mg Current Unavailable Commercial Changes / Commercial viability 22/09/2025 thiotepa Injection, powder for 100 mg Current Unavailable Commercial Changes / Commercial viability 22/09/2025 thiotepa Injection, powder for 400 mg Current Unavailable Commercial Changes / Commercial viability 22/09/2025 nitrofurantoin Capsule, hard 100 mg Current Limited Availability Manufacturing 22/09/2025 clindamycin phosphate Cream 22.8 mg/g Current Limited Availability Transport / Logistic issues / Storage capacity issues 22/09/2025 midazolam Injection, solution 1 mg/mL Current Unavailable Manufacturing 22/09/2025 methylphenidate hydrochloride Capsule, modified release 20 mg Current Limited Availability Manufacturing 22/09/2025 galantamine hydrobromide~galantamine Capsule, modified release 20.51 mg~16 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 22/09/2025